Tissue	O
transglutaminase-dependent	O
posttranslational	O
modification	O
of	O
the	O
retinoblastoma	B-protein
gene	I-protein
product	I-protein
in	O
promonocytic	B-cell_line
cells	I-cell_line
undergoing	O
apoptosis	O
.	O

The	O
retinoblastoma	B-protein
gene	I-protein
product	I-protein
(	O
pRB	B-protein
)	O
plays	O
an	O
important	O
role	O
in	O
controlling	O
both	O
cell	O
release	O
from	O
the	O
G1	O
phase	O
and	O
apoptosis	O
.	O

We	O
show	O
here	O
that	O
in	O
the	O
early	O
phases	O
of	O
apoptosis	O
,	O
pRB	B-protein
is	O
posttranslationally	O
modified	O
by	O
a	O
tissue	O
transglutaminase	O
(	O
tTG	B-protein
)	O
-catalyzed	O
reaction	O
.	O

In	O
fact	O
,	O
by	O
employing	O
a	O
novel	O
haptenized	O
lysis	O
synthetic	O
substrate	O
which	O
allows	O
the	O
isolation	O
of	O
glutaminyl-tTG	O
substrates	O
in	O
vivo	O
,	O
we	O
identified	O
pRB	B-protein
as	O
a	O
potential	O
tTG	O
substrate	O
in	O
U937	B-cell_line
cells	I-cell_line
undergoing	O
apoptosis	O
.	O

In	O
keeping	O
with	O
this	O
finding	O
,	O
we	O
showed	O
that	O
apoptosis	O
of	O
U937	B-cell_line
cells	I-cell_line
is	O
characterized	O
by	O
the	O
rapid	O
disappearance	O
of	O
the	O
105	O
,	O
000-	O
to	O
110	O
,	O
000-molecular-weight	O
pRB	B-protein
forms	O
concomitantly	O
with	O
the	O
appearance	O
of	O
a	O
smear	O
of	O
immunoreactive	O
products	O
with	O
a	O
molecular	O
weight	O
of	O
greater	O
than	O
250	O
,	O
000	O
.	O

The	O
shift	O
in	O
pRB	B-protein
molecular	O
weight	O
was	O
reproduced	O
by	O
adding	O
exogenous	O
purified	O
tTG	O
to	O
extracts	O
obtained	O
from	O
viable	O
U937	B-cell_line
cells	I-cell_line
and	O
was	O
prevented	O
by	O
dansylcadaverine	O
,	O
a	O
potent	O
enzyme	O
inhibitor	O
.	O

The	O
effect	O
of	O
the	O
pRB	B-protein
posttranslational	O
modification	O
during	O
apoptosis	O
was	O
investigated	O
by	O
determining	O
the	O
E2F-1	B-protein
levels	O
and	O
by	O
isolating	O
and	O
characterizing	O
pRB-null	B-cell_line
clones	I-cell_line
from	O
U937	B-cell_line
cells	I-cell_line
.	O

Notably	O
,	O
the	O
lack	O
of	O
pRB	B-protein
in	O
these	O
U937-derived	B-cell_line
clones	I-cell_line
renders	O
these	O
p53-null	B-cell_line
cells	I-cell_line
highly	O
resistant	O
to	O
apoptosis	O
induced	O
by	O
serum	O
withdrawal	O
,	O
calphostin	O
C	O
,	O
and	O
ceramide	O
.	O

Taken	O
together	O
,	O
these	O
data	O
suggest	O
that	O
tTG	B-protein
,	O
acting	O
on	O
the	O
pRB	B-protein
protein	I-protein
,	O
might	O
play	O
an	O
important	O
role	O
in	O
the	O
cell	O
progression	O
through	O
the	O
death	O
program	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Oct.	NULL
1997	NULL
,	NULL
p.	NULL
6040-6048	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

10	NULL
Tissue	NULL
Transglutaminase-Dependent	NULL
Posttranslational	NULL
Modification	NULL
of	NULL
the	NULL
Retinoblastoma	NULL
Gene	NULL
Product	NULL
in	NULL
Promonocytic	NULL
Cells	NULL
Undergoing	NULL
Apoptosis	NULL
SERAFINA	NULL
OLIVERIO	NULL
,	NULL
'	NULL
ALESSANDRA	NULL
AMENDOLA	NULL
,	NULL
*	NULL
FEDERICA	NULL
DI	NULL
SANO	NULL
,	NULL
``	NULL
MARIA	NULL
GRAZIA	NULL
FARRACE	NULL
,	NULL
``	NULL
LASZLO	NULL
FESUS	NULL
,	NULL
``	NULL
ZOLTAN	NULL
NEMES	NULL
,	NULL
``	NULL
LUCIA	NULL
PIREDDA	NULL
,	NULL
!	NULL

ANGELO	NULL
SPINEDI	NULL
,	NULL
*	NULL
anp	NULL
MAURO	NULL
PIACENTINT	NULL
'	NULL
*	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Rome	NULL
``	NULL
Tor	NULL
Vergata	NULL
,	NULL
``	NULL
Rome	NULL
,	NULL
Italy	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
University	NULL
Medical	NULL
School	NULL
of	NULL
Debrecen	NULL
,	NULL
Debrecen	NULL
,	NULL
Hungary®	NULL
Received	NULL
14	NULL
April	NULL
1997/Returned	NULL
for	NULL
modification	NULL
13	NULL
May	NULL
1997/Accepted	NULL
13	NULL
June	NULL
1997	NULL
The	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
(	NULL
pRB	NULL
)	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
controlling	NULL
both	NULL
cell	NULL
release	NULL
from	NULL
the	NULL
G	NULL
;	NULL
,	NULL
phase	NULL
and	NULL
apoptosis	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
in	NULL
the	NULL
early	NULL
phases	NULL
of	NULL
apoptosis	NULL
,	NULL
pRB	NULL
is	NULL
posttranslationally	NULL
modified	NULL
by	NULL
a	NULL
tissue	NULL
transglutaminase	NULL
(	NULL
tTG	NULL
)	NULL
-catalyzed	NULL
reaction	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
by	NULL
employing	NULL
a	NULL
novel	NULL
haptenized	NULL
lysis	NULL
synthetic	NULL
substrate	NULL
which	NULL
allows	NULL
the	NULL
isolation	NULL
of	NULL
glutaminyl-tTG	NULL
substrates	NULL
in	NULL
vivo	NULL
,	NULL
we	NULL
identified	NULL
pRB	NULL
as	NULL
a	NULL
potential	NULL
tTG	NULL
substrate	NULL
in	NULL
U937	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
this	NULL
finding	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
apoptosis	NULL
of	NULL
U937	NULL
cells	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
rapid	NULL
disappearance	NULL
of	NULL
the	NULL
105,000-	NULL
to	NULL
110,000-molecular-weight	NULL
pRB	NULL
forms	NULL
concomitantly	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
smear	NULL
of	NULL
immunoreactive	NULL
products	NULL
with	NULL
a	NULL
molecular	NULL
weight	NULL
of	NULL
greater	NULL
than	NULL
250,000	NULL
.	NULL

The	NULL
shift	NULL
in	NULL
pRB	NULL
molecular	NULL
weight	NULL
was	NULL
reproduced	NULL
by	NULL
adding	NULL
exogenous	NULL
purified	NULL
tTG	NULL
to	NULL
extracts	NULL
obtained	NULL
from	NULL
viable	NULL
U937	NULL
cells	NULL
and	NULL
was	NULL
prevented	NULL
by	NULL
dansylcadaverine	NULL
,	NULL
a	NULL
potent	NULL
enzyme	NULL
inhibitor	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
pRB	NULL
posttranslational	NULL
modification	NULL
during	NULL
apoptosis	NULL
was	NULL
investigated	NULL
by	NULL
determining	NULL
the	NULL
E2F-1	NULL
levels	NULL
and	NULL
by	NULL
isolating	NULL
and	NULL
characterizing	NULL
pRB-null	NULL
clones	NULL
from	NULL
U937	NULL
cells	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
pRB	NULL
in	NULL
these	NULL
U937-derived	NULL
clones	NULL
renders	NULL
these	NULL
p53-null	NULL
cells	NULL
highly	NULL
resistant	NULL
to	NULL
apoptosis	NULL
induced	NULL
by	NULL
serum	NULL
withdrawal	NULL
,	NULL
calphostin	NULL
C	NULL
,	NULL
and	NULL
ceramide	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
tTG	NULL
,	NULL
acting	NULL
on	NULL
the	NULL
pRB	NULL
protein	NULL
,	NULL
might	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
cell	NULL
progression	NULL
through	NULL
the	NULL
death	NULL
program	NULL
.	NULL

Transglutaminases	NULL
belong	NULL
to	NULL
a	NULL
family	NULL
of	NULL
Ca**-dependent	NULL
enzymes	NULL
that	NULL
catalyze	NULL
cross-linking	NULL
of	NULL
polypeptide	NULL
chains	NULL
in	NULL
which	NULL
the	NULL
y-carboxamide	NULL
groups	NULL
of	NULL
peptide-bound	NULL
glutamine	NULL
residues	NULL
serve	NULL
as	NULL
acyl	NULL
donors	NULL
and	NULL
primary	NULL
amino	NULL
groups	NULL
of	NULL
several	NULL
compounds	NULL
function	NULL
as	NULL
acceptor	NULL
substrates	NULL
(	NULL
13-15	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
results	NULL
in	NULL
the	NULL
posttranslational	NULL
modification	NULL
of	NULL
proteins	NULL
by	NULL
establishing	NULL
g	NULL
(	NULL
y-glutamyl	NULL
)	NULL
lysine	NULL
cross-linkages	NULL
and/or	NULL
covalent	NULL
incorporation	NULL
of	NULL
biogenic	NULL
amines	NULL
(	NULL
di-	NULL
and	NULL
polyamines	NULL
and	NULL
histamine	NULL
)	NULL
into	NULL
proteins	NULL
(	NULL
13	NULL
,	NULL
37	NULL
)	NULL
.	NULL

The	NULL
transglutaminase-dependent	NULL
formation	NULL
of	NULL
stable	NULL
cross-links	NULL
induces	NULL
protein	NULL
polymerization	NULL
which	NULL
confers	NULL
high	NULL
resistance	NULL
to	NULL
mechanical	NULL
and	NULL
chemical	NULL
attack	NULL
to	NULL
the	NULL
polypeptides	NULL
involved	NULL
in	NULL
the	NULL
linkage	NULL
(	NULL
11	NULL
,	NULL
13	NULL
)	NULL
;	NULL
in	NULL
fact	NULL
,	NULL
these	NULL
polymers	NULL
can	NULL
be	NULL
destroyed	NULL
only	NULL
by	NULL
proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
protein	NULL
chains	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Tissue	NULL
transglutaminase	NULL
(	NULL
tTG	NULL
)	NULL
binds	NULL
guanine	NULL
nucleotides	NULL
and	NULL
hydrolyzes	NULL
GTP	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Nakaoka	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
have	NULL
demonstrated	NULL
that	NULL
the	NULL
74-kDa	NULL
a	NULL
subunit	NULL
(	NULL
G	NULL
,	NULL
,	NULL
,	NULL
)	NULL
associated	NULL
with	NULL
the	NULL
50-kDa	NULL
B	NULL
subunit	NULL
of	NULL
the	NULL
GTP-binding	NULL
protein	NULL
,	NULL
G	NULL
,	NULL
,	NULL
,	NULL
is	NULL
tTG	NULL
.	NULL

This	NULL
dimer	NULL
acts	NULL
in	NULL
association	NULL
with	NULL
the	NULL
rat	NULL
liver	NULL
a	NULL
,	NULL
-adrenergic	NULL
receptor	NULL
in	NULL
a	NULL
ternary	NULL
complex	NULL
.	NULL

Thus	NULL
,	NULL
G	NULL
,	NULL
,	NULL
,	NULL
(	NULL
tTG	NULL
)	NULL
is	NULL
a	NULL
multifunctional	NULL
protein	NULL
which	NULL
not	NULL
only	NULL
acts	NULL
as	NULL
a	NULL
transglutaminase	NULL
but	NULL
,	NULL
by	NULL
binding	NULL
GTP	NULL
(	NULL
in	NULL
a	NULL
G	NULL
,	NULL
,	NULL
,	NULL
,	NULL
-GTP	NULL
complex	NULL
)	NULL
,	NULL
activates	NULL
phospholipase	NULL
C	NULL
after	NULL
receptor	NULL
stimulation	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
much	NULL
emphasis	NULL
has	NULL
been	NULL
given	NULL
to	NULL
the	NULL
genetic	NULL
control	NULL
exerted	NULL
by	NULL
various	NULL
regulatory	NULL
elements	NULL
during	NULL
the	NULL
early	NULL
phases	NULL
of	NULL
the	NULL
death	NULL
program	NULL
,	NULL
which	NULL
results	NULL
in	NULL
the	NULL
synthesis	NULL
and/or	NULL
activation	NULL
of	NULL
effector	NULL
killer	NULL
genes	NULL
(	NULL
8	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
tTG	NULL
gene	NULL
is	NULL
one	NULL
of	NULL
the	NULL
few	NULL
genes	NULL
induced	NULL
during	NULL
apoptosis	NULL
(	NULL
17	NULL
,	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
tTG	NULL
protein	NULL
is	NULL
undetectable	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
cells	NULL
,	NULL
and	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Rome	NULL
``	NULL
Tor	NULL
Vergata	NULL
,	NULL
``	NULL
Via	NULL
della	NULL
Ricerca	NULL
Scientifica	NULL
00133	NULL
Rome	NULL
,	NULL
Italy	NULL
.	NULL

Phone	NULL
:	NULL
00396-72594370	NULL
.	NULL

Fax	NULL
:	NULL
00396-2023500	NULL
.	NULL

6040	NULL
its	NULL
mRNA	NULL
is	NULL
transcribed	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
(	NULL
38	NULL
,	NULL
39	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
tTG	NULL
gene	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
some	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
endothelial	NULL
cells	NULL
,	NULL
smooth	NULL
muscle	NULL
cells	NULL
,	NULL
and	NULL
mesangial	NULL
cells	NULL
in	NULL
vivo	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
39	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
tTG	NULL
not	NULL
only	NULL
is	NULL
associated	NULL
with	NULL
apoptosis	NULL
but	NULL
in	NULL
some	NULL
cell	NULL
types	NULL
may	NULL
also	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
killing	NULL
process	NULL
(	NULL
14	NULL
,	NULL
30	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
tTG	NULL
in	NULL
human	NULL
neuroblastoma	NULL
SK-N-BE	NULL
(	NULL
2	NULL
)	NULL
cells	NULL
,	NULL
L929	NULL
cells	NULL
,	NULL
and	NULL
NIH	NULL
3T3	NULL
fibroblasts	NULL
enhances	NULL
their	NULL
susceptibility	NULL
to	NULL
undergo	NULL
apoptosis	NULL
(	NULL
14	NULL
,	NULL
30	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Human	NULL
neuroblastoma	NULL
cells	NULL
overexpressing	NULL
tTG	NULL
showed	NULL
a	NULL
large	NULL
reduction	NULL
in	NULL
their	NULL
growth	NULL
capacity	NULL
,	NULL
not	NULL
only	NULL
in	NULL
vitro	NULL
but	NULL
also	NULL
when	NULL
xenografted	NULL
into	NULL
SCID	NULL
mice	NULL
(	NULL
30	NULL
,	NULL
40	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
transfection	NULL
of	NULL
the	NULL
same	NULL
neuroblastoma	NULL
cells	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
human	NULL
tTG	NULL
cDNA	NULL
in	NULL
the	NULL
antisense	NULL
orientation	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
of	NULL
both	NULL
spontaneous	NULL
and	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
-induced	NULL
apoptosis	NULL
(	NULL
30	NULL
)	NULL
.	NULL

It	NULL
is	NULL
difficult	NULL
at	NULL
the	NULL
moment	NULL
to	NULL
establish	NULL
the	NULL
precise	NULL
position	NULL
of	NULL
tTG	NULL
in	NULL
the	NULL
cascade	NULL
of	NULL
events	NULL
leading	NULL
to	NULL
apoptosis	NULL
.	NULL

However	NULL
,	NULL
a	NULL
large	NULL
body	NULL
of	NULL
evidence	NULL
indicates	NULL
that	NULL
tTG	NULL
induction	NULL
parallels	NULL
or	NULL
slightly	NULL
precedes	NULL
be/-2	NULL
downregulation	NULL
and	NULL
is	NULL
not	NULL
susceptible	NULL
to	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
Bel-2	NULL
protein	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
present	NULL
study	NULL
was	NULL
undertaken	NULL
to	NULL
investigate	NULL
whether	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
apoptosis	NULL
,	NULL
the	NULL
controlled	NULL
tTG-mediated	NULL
posttranslational	NULL
modification	NULL
of	NULL
a	NULL
specific	NULL
protein	NULL
substrate	NULL
(	NULL
s	NULL
)	NULL
might	NULL
have	NULL
a	NULL
role	NULL
in	NULL
cell	NULL
commitment	NULL
to	NULL
apoptosis	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Chemicals	NULL
.	NULL

[	NULL
1,4-	NULL
(	NULL
#	NULL
)	NULL
-*HJputrescine	NULL
dihydrochloride	NULL
(	NULL
26.3	NULL
Ci/mmol	NULL
)	NULL
was	NULL
from	NULL
Amersham	NULL
(	NULL
Bucks	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

Optifluor	NULL
was	NULL
from	NULL
Packard	NULL
(	NULL
Zurich	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

N	NULL
,	NULL
V'-Dimethylcasein	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
and	NULL
putrescine	NULL
hy-drochloride	NULL
were	NULL
from	NULL
Fluka	NULL
(	NULL
Bucks	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
media	NULL
and	NULL
plastic	NULL
were	NULL
from	NULL
Flow	NULL
(	NULL
Irving	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
.	NULL

All-frans-RA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
,	NULL
guinea	NULL
pig	NULL
liver	NULL
tTG	NULL
,	NULL
dansylcadaverine	NULL
,	NULL
and	NULL
propidium	NULL
iodide	NULL
were	NULL
voL	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
Mo	NULL
.	NULL
)	NULL

.	NULL

Calphostin	NULL
C	NULL
was	NULL
from	NULL
Calbiochem	NULL
Novachem	NULL
Co.	NULL
(	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
1-glutamine	NULL
,	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
was	NULL
from	NULL
Seralab	NULL
Ltd.	NULL
(	NULL
Crawley	NULL
Down	NULL
,	NULL
United	NULL
Kingdom	NULL
}	NULL
.	NULL

Streptavidin-biotin	NULL
immunoper-oxidase	NULL
staining	NULL
systems	NULL
were	NULL
from	NULL
BioGenex	NULL
(	NULL
San	NULL
Ramon	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Anti-human	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
pRB	NULL
)	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
Inc.	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

The	NULL
anti-human	NULL
E2F-1	NULL
antibody	NULL
was	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnologies	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

The	NULL
parental	NULL
U937	NULL
cell	NULL
line	NULL
was	NULL
grown	NULL
at	NULL
37°C	NULL
,	NULL
under	NULL
a	NULL
humidified	NULL
atmosphere	NULL
containing	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
,	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
heat-inactivated	NULL
FCS	NULL
,	NULL
2	NULL
mM	NULL
1-glutamine	NULL
,	NULL
100	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
100	NULL
mg	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
prior	NULL
to	NULL
treatment	NULL
with	NULL
calphostin	NULL
C	NULL
,	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°/ml	NULL
)	NULL
were	NULL
shifted	NULL
overnight	NULL
to	NULL
a	NULL
growth	NULL
medium	NULL
containing	NULL
0.5	NULL
%	NULL
serum	NULL
.	NULL

Drug	NULL
administration	NULL
and	NULL
the	NULL
initial	NULL
20-min	NULL
incubation	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
dark	NULL
;	NULL
cells	NULL
were	NULL
then	NULL
exposed	NULL
to	NULL
light	NULL
for	NULL
a	NULL
further	NULL
20	NULL
min	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
allowed	NULL
to	NULL
proceed	NULL
in	NULL
an	NULL
incubator	NULL
with	NULL
occasional	NULL
cell	NULL
exposure	NULL
to	NULL
microscope	NULL
light	NULL
;	NULL
control	NULL
samples	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
proper	NULL
amounts	NULL
of	NULL
carrier	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
and	NULL
run	NULL
in	NULL
parallel	NULL
.	NULL

In	NULL
those	NULL
experiments	NULL
employing	NULL
dansyleadaverine	NULL
(	NULL
1	NULL
mM	NULL
final	NULL
concentration	NULL
)	NULL
,	NULL
the	NULL
tTG	NULL
inhibitor	NULL
was	NULL
added	NULL
1	NULL
h	NULL
before	NULL
calphostin	NULL
C	NULL
administration	NULL
.	NULL

For	NULL
the	NULL
RA	NULL
studies	NULL
,	NULL
cells	NULL
were	NULL
plated	NULL
at	NULL
50	NULL
X	NULL
10°	NULL
cells/cm	NULL
``	NULL
in	NULL
growth	NULL
medium	NULL
containing	NULL
1	NULL
uM	NULL
RA	NULL
(	NULL
from	NULL
a	NULL
5	NULL
mM	NULL
stock	NULL
solution	NULL
dissolved	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
)	NULL
and	NULL
1.25	NULL
%	NULL
DMSO	NULL
.	NULL

Medium	NULL
was	NULL
replaced	NULL
daily	NULL
.	NULL

Control	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
0.07	NULL
%	NULL
ethanol	NULL
.	NULL

Cell	NULL
numbers	NULL
and	NULL
viability	NULL
were	NULL
evaluated	NULL
in	NULL
a	NULL
Thoma	NULL
hemocy-tometer	NULL
chamber	NULL
.	NULL

For	NULL
the	NULL
isolation	NULL
of	NULL
DALP	NULL
{	NULL
3-	NULL
[	NULL
N-	NULL
«	NULL
,	NULL
Ne-	NULL
(	NULL
2',4'-dinitrophenyl	NULL
)	NULL
-amino-z-hex-anoyl-L-lysylamido	NULL
}	NULL
-propane-1-ol	NULL
}	NULL
-labeled	NULL
protein	NULL
,	NULL
lysates	NULL
obtained	NULL
from	NULL
U937	NULL
cells	NULL
treated	NULL
for	NULL
72	NULL
h	NULL
with	NULL
RA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1.25	NULL
%	NULL
DMSO	NULL
were	NULL
precipitated	NULL
with	NULL
cold	NULL
acetone	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
100	NULL
%	NULL
trifluoroacetic	NULL
acid	NULL
for	NULL
30	NULL
min	NULL
on	NULL
ice	NULL
to	NULL
hydrolyze	NULL
carbamate	NULL
esters	NULL
,	NULL
lyophilized	NULL
,	NULL
and	NULL
redissolved	NULL
in	NULL
2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-125	NULL
mM	NULL
Tris-HCI	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
-0.01	NULL
%	NULL
bromophenol	NULL
blue	NULL
.	NULL

The	NULL
sample	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
PrepCell	NULL
491	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Hercules	NULL
,	NULL
Calif.	NULL
)	NULL
filled	NULL
with	NULL
3	NULL
%	NULL
gel	NULL
.	NULL

Isolated	NULL
proteins	NULL
were	NULL
applied	NULL
to	NULL
a	NULL
column	NULL
(	NULL
0.5	NULL
by	NULL
5	NULL
cm	NULL
)	NULL
filled	NULL
with	NULL
rabbit	NULL
anti-dinitrophenyl	NULL
immunoglobulins	NULL
coupled	NULL
with	NULL
hydra-zide-linked	NULL
beads	NULL
prepared	NULL
with	NULL
an	NULL
Affi-gel	NULL
Hz	NULL
immunoaffinity	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
)	NULL
.	NULL

Affinity-purified	NULL
proteins	NULL
were	NULL
released	NULL
from	NULL
the	NULL
beads	NULL
by	NULL
boiling	NULL
in	NULL
2	NULL
%	NULL
SDS-125	NULL
mM	NULL
Tris-HCI	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

tTG	NULL
assay	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
(	NULL
without	NULL
Ca**	NULL
and	NULL
Mg**	NULL
)	NULL
and	NULL
sonicated	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
s.	NULL
tTG	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
detecting	NULL
the	NULL
incorporation	NULL
of	NULL
[	NULL
*HJputrescine	NULL
into	NULL
N	NULL
,	NULL
N'-dimethyleasein	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Determination	NULL
of	NULL
tTG	NULL
protein	NULL
in	NULL
both	NULL
RA-treated	NULL
and	NULL
untreated	NULL
U937	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Aliquots	NULL
(	NULL
50	NULL
to	NULL
300	NULL
ug	NULL
)	NULL
of	NULL
total	NULL
protein	NULL
were	NULL
suspended	NULL
in	NULL
0.1	NULL
M	NULL
Tris-HCl	NULL
buffer	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
containing	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
0.05	NULL
%	NULL
B-mercaptocthanol	NULL
,	NULL
2.5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.001	NULL
%	NULL
bromophenol	NULL
blue	NULL
and	NULL
boiled	NULL
for	NULL
3	NULL
min	NULL
.	NULL

The	NULL
extract	NULL
was	NULL
subjected	NULL
to	NULL
SDS-10.5	NULL
%	NULL
PAGE	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Apoptosis	NULL
detection	NULL
.	NULL

Apoptosis	NULL
was	NULL
determined	NULL
by	NULL
both	NULL
morphological	NULL
and	NULL
flow	NULL
cytometric	NULL
analyses	NULL
(	NULL
24	NULL
)	NULL
.	NULL

For	NULL
flow	NULL
cytometric	NULL
analysis	NULL
,	NULL
aliquot	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
centrifuged	NULL
at	NULL
300	NULL
x	NULL
g	NULL
for	NULL
5	NULL
min	NULL
;	NULL
pellets	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
placed	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
overlaid	NULL
with	NULL
0.5	NULL
ml	NULL
of	NULL
a	NULL
solution	NULL
containing	NULL
200	NULL
g	NULL
of	NULL
propidium	NULL
iodide	NULL
per	NULL
ml	NULL
,	NULL
1.0	NULL
%	NULL
Triton	NULL
,	NULL
and	NULL
0.9	NULL
%	NULL
NaCl	NULL
.	NULL

After	NULL
gentle	NULL
resuspension	NULL
in	NULL
this	NULL
solution	NULL
,	NULL
cells	NULL
were	NULL
left	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
light	NULL
,	NULL
before	NULL
analysis	NULL
.	NULL

Propidium	NULL
iodide-stained	NULL
cells	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
FACScan	NULL
flow	NULL
cytometer	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Bedford	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

;	NULL
fluorescence	NULL
was	NULL
measured	NULL
between	NULL
565	NULL
and	NULL
605	NULL
nm	NULL
.	NULL

The	NULL
data	NULL
were	NULL
acquired	NULL
and	NULL
analyzed	NULL
with	NULL
the	NULL
Lysis	NULL
II	NULL
program	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Western	NULL
blotting	NULL
.	NULL

Western	NULL
blotting	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
30	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
aliquots	NULL
of	NULL
total	NULL
protein	NULL
extracts	NULL
(	NULL
100	NULL
mg	NULL
)	NULL
from	NULL
cells	NULL
after	NULL
different	NULL
treatments	NULL
were	NULL
suspended	NULL
in	NULL
0.1	NULL
M	NULL
Tris-HCl	NULL
buffer	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
containing	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
0.05	NULL
%	NULL
B-mercaptocthanol	NULL
,	NULL
2.5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.001	NULL
%	NULL
bromophenol	NULL
blue	NULL
,	NULL
boiled	NULL
for	NULL
3	NULL
min	NULL
,	NULL
and	NULL
subsequently	NULL
size	NULL
fractionated	NULL
by	NULL
SDS-7.5	NULL
%	NULL
PAGE	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
electroblotted	NULL
overnight	NULL
onto	NULL
nitrocellulose	NULL
paper	NULL
at	NULL
40	NULL
mA	NULL
,	NULL
and	NULL
the	NULL
bands	NULL
were	NULL
revealed	NULL
with	NULL
horseradish	NULL
peroxidase-conjugated	NULL
goat	NULL
anti-mouse	NULL
or	NULL
anti-human	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
(	NULL
Bio-Rad	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
developed	NULL
with	NULL
the	NULL
ECL	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Molecular	NULL
weights	NULL
(	NULL
MWs	NULL
)	NULL
were	NULL
evaluated	NULL
by	NULL
plotting	NULL
R	NULL
,	NULL
against	NULL
log	NULL
MW	NULL
with	NULL
the	NULL
Rainbow	NULL
protein	NULL
high-	NULL
MW	NULL
markers	NULL
(	NULL
Amersham	NULL
)	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

Inmunohistochemistry	NULL
.	NULL

Immunohistochemical	NULL
staining	NULL
of	NULL
human	NULL
U937	NULL
cells	NULL
was	NULL
performed	NULL
with	NULL
,	NULL
as	NULL
the	NULL
primary	NULL
antibody	NULL
,	NULL
an	NULL
affinity-purified	NULL
monospecific	NULL
IgG	NULL
raised	NULL
in	NULL
rabbits	NULL
against	NULL
human	NULL
erythrocyte-soluble	NULL
tTG	NULL
(	NULL
1:100	NULL
)	NULL
(	NULL
9	NULL
)	NULL
;	NULL
the	NULL
anti-human	NULL
Bcel-2	NULL
was	NULL
from	NULL
Dako	NULL
(	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

Incubations	NULL
with	NULL
the	NULL
primary	NULL
antibody	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
wet	NULL
chamber	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

A	NULL
biotin-ylated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
was	NULL
used	NULL
as	NULL
the	NULL
second	NULL
antibody	NULL
,	NULL
followed	NULL
by	NULL
a	NULL
preformed	NULL
streptavidin-horseradish	NULL
peroxidase	NULL
complex	NULL
(	NULL
BioGenex	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
developed	NULL
by	NULL
using	NULL
aminoethylcarbazole	NULL
(	NULL
CRL	NULL
,	NULL
Richmond	NULL
,	NULL
Va.	NULL
)	NULL
as	NULL
a	NULL
chromogen	NULL
substrate	NULL
and	NULL
0.01	NULL
%	NULL
H	NULL
,	NULL
O	NULL
;	NULL
,	NULL
.	NULL

Cells	NULL
were	NULL
counterstained	NULL
in	NULL
Mayer	NULL
's	NULL
hemalum	NULL
.	NULL

TISSUE	NULL
TRANSGLUTAMINASE	NULL
AND	NULL
pRB	NULL
IN	NULL
APOPTOSIS	NULL
-	NULL
6041	NULL
RESULTS	NULL
Identification	NULL
of	NULL
tTG	NULL
substrate	NULL
proteins	NULL
in	NULL
U937	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

We	NULL
used	NULL
DALP	NULL
,	NULL
a	NULL
novel	NULL
synthetic	NULL
substrate	NULL
of	NULL
tTG	NULL
that	NULL
is	NULL
able	NULL
to	NULL
permeate	NULL
cells	NULL
,	NULL
to	NULL
isolate	NULL
and	NULL
identify	NULL
glutaminyl-tTG	NULL
substrate	NULL
proteins	NULL
in	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
substrate	NULL
properties	NULL
of	NULL
DALP	NULL
were	NULL
tested	NULL
by	NULL
detecting	NULL
its	NULL
tTG-dependent	NULL
incorporation	NULL
into	NULL
dimethyl-ated	NULL
casein	NULL
and	NULL
identification	NULL
of	NULL
y-glutamyl-DALP	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
K	NULL
,	NULL
,	NULL
of	NULL
DALP	NULL
(	NULL
3	NULL
LM	NULL
)	NULL
is	NULL
about	NULL
50-fold	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
best	NULL
available	NULL
amine	NULL
substrate	NULL
of	NULL
tTG	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
carbamate	NULL
methyl	NULL
ester	NULL
derivative	NULL
of	NULL
DALP	NULL
is	NULL
nontoxic	NULL
and	NULL
easily	NULL
penetrates	NULL
into	NULL
the	NULL
U937	NULL
cells	NULL
,	NULL
where	NULL
is	NULL
hydrolyzed	NULL
by	NULL
cellular	NULL
esterases	NULL
and	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tTG	NULL
,	NULL
covalently	NULL
incorporates	NULL
into	NULL
cellular	NULL
proteins	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Proteins	NULL
bearing	NULL
the	NULL
haptenic	NULL
group	NULL
were	NULL
isolated	NULL
from	NULL
U937	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
upon	NULL
treatment	NULL
with	NULL
RA	NULL
,	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
tTG	NULL
and	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
;	NULL
see	NULL
reference	NULL
39	NULL
for	NULL
a	NULL
review	NULL
)	NULL
,	NULL
by	NULL
immunoaffinity	NULL
chro-matography	NULL
with	NULL
antibodies	NULL
against	NULL
the	NULL
dinitrophenyl	NULL
haptenic	NULL
group	NULL
of	NULL
DALP	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
isolated	NULL
proteins	NULL
revealed	NULL
that	NULL
the	NULL
major	NULL
DALP-labeled	NULL
proteins	NULL
in	NULL
U937	NULL
undergoing	NULL
apoptosis	NULL
had	NULL
molecular	NULL
masses	NULL
of	NULL
43	NULL
,	NULL
90	NULL
,	NULL
and	NULL
110	NULL
kDa	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
we	NULL
isolated	NULL
protein	NULL
aggregates	NULL
which	NULL
could	NULL
not	NULL
enter	NULL
the	NULL
gel	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
no	NULL
substrate	NULL
proteins	NULL
were	NULL
isolated	NULL
from	NULL
viable	NULL
U937	NULL
cells	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
they	NULL
act	NULL
as	NULL
a	NULL
tTG	NULL
substrate	NULL
only	NULL
in	NULL
U937	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

By	NULL
immunostaining	NULL
the	NULL
blots	NULL
obtained	NULL
from	NULL
the	NULL
affinity-purified	NULL
proteins	NULL
with	NULL
the	NULL
C15	NULL
anti-human	NULL
pRB	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
band	NULL
showing	NULL
an	NULL
MW	NULL
of	NULL
110,000	NULL
was	NULL
specifically	NULL
recognized	NULL
by	NULL
the	NULL
anti-pRB	NULL
MAb	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
;	NULL
the	NULL
same	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
using	NULL
an	NULL
anti-pRB	NULL
MAb	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
619	NULL
to	NULL
928	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
SDS-insoluble	NULL
high-	NULL
MW	NULL
protein	NULL
complex	NULL
was	NULL
also	NULL
stained	NULL
,	NULL
suggesting	NULL
that	NULL
pRB	NULL
might	NULL
be	NULL
incorporated	NULL
into	NULL
this	NULL
large	NULL
protein	NULL
polymer	NULL
as	NULL
a	NULL
conseque	NULL
of	NULL
a	NULL
tTG-dependent	NULL
reaction	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
the	NULL
43-kDa	NULL
tTG	NULL
protein	NULL
substrate	NULL
isolated	NULL
with	NULL
an	NULL
immunoaffinity	NULL
column	NULL
and	NULL
not	NULL
stained	NULL
by	NULL
the	NULL
two	NULL
anti-pRB	NULL
MAbs	NULL
was	NULL
identified	NULL
as	NULL
actin	NULL
(	NULL
35	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
pRB	NULL
may	NULL
indeed	NULL
act	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
tTG	NULL
in	NULL
U937	NULL
cells	NULL
,	NULL
we	NULL
incubated	NULL
crude	NULL
U937	NULL
cell	NULL
extracts	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
purified	NULL
tTG	NULL
for	NULL
60	NULL
min	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
the	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-7.5	NULL
%	NULL
PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
previously	NULL
reported	NULL
anti-human	NULL
pRB	NULL
MAb	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

In	NULL
control	NULL
cells	NULL
,	NULL
this	NULL
antibody	NULL
evidenced	NULL
a	NULL
broad	NULL
band	NULL
in	NULL
the	NULL
105-	NULL
to	NULL
110-kDa	NULL
area	NULL
,	NULL
corresponding	NULL
to	NULL
pRB	NULL
in	NULL
different	NULL
phosphorylation	NULL
states	NULL
,	NULL
and	NULL
a	NULL
smaller	NULL
68-kDa	NULL
product	NULL
recently	NULL
identified	NULL
in	NULL
U937	NULL
cells	NULL
as	NULL
one	NULL
of	NULL
the	NULL
cleavage	NULL
products	NULL
of	NULL
pRB	NULL
by	NULL
caspase	NULL
(	NULL
5	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
tTG	NULL
brought	NULL
about	NULL
a	NULL
dramatic	NULL
modification	NULL
of	NULL
this	NULL
pattern	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
rapid	NULL
disappearance	NULL
of	NULL
the	NULL
pRB	NULL
105-	NULL
to	NULL
110-kDa	NULL
immunopositive	NULL
band	NULL
(	NULL
s	NULL
)	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
smear	NULL
of	NULL
products	NULL
with	NULL
molecular	NULL
masses	NULL
higher	NULL
than	NULL
250	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

pRB	NULL
acts	NULL
as	NULL
a	NULL
tTG	NULL
substrate	NULL
in	NULL
U937	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

Calphostin	NULL
C	NULL
,	NULL
a	NULL
potent	NULL
and	NULL
selective	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitor	NULL
(	NULL
6	NULL
)	NULL
,	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
various	NULL
cell	NULL
systems	NULL
(	NULL
23	NULL
,	NULL
28	NULL
)	NULL
and	NULL
to	NULL
sensitize	NULL
cells	NULL
to	NULL
apoptosis	NULL
induced	NULL
by	NULL
other	NULL
agents	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
U937	NULL
cells	NULL
maintained	NULL
in	NULL
0.5	NULL
%	NULL
serum	NULL
and	NULL
treated	NULL
with	NULL
250	NULL
nM	NULL
calphostin	NULL
C	NULL
,	NULL
the	NULL
onset	NULL
of	NULL
apoptosis	NULL
was	NULL
observed	NULL
1	NULL
h	NULL
after	NULL
drug	NULL
administration	NULL
,	NULL
and	NULL
by	NULL
3	NULL
h	NULL
about	NULL
70	NULL
to	NULL
80	NULL
%	NULL
of	NULL
cells	NULL
had	NULL
died	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Figure	NULL
3b	NULL
shows	NULL
that	NULL
calphostin	NULL
C-induced	NULL
apoptosis	NULL
,	NULL
at	NULL
its	NULL
onset	NULL
,	NULL
was	NULL
consistent	NULL
with	NULL
a	NULL
selective	NULL
loss	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cycle	NULL
.	NULL

It	NULL
has	NULL
been	NULL
established	NULL
that	NULL
multiple	NULL
phosphorylation	NULL
of	NULL
pRB	NULL
is	NULL
a	NULL
key	NULL
event	NULL
in	NULL
the	NULL
control	NULL
of	NULL
G	NULL
,	NULL
-to-S	NULL
cell	NULL
cycle	NULL
phase	NULL
transition	NULL
and	NULL
apoptosis	NULL
(	NULL
22	NULL
,	NULL
43	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
6042	NULL
OLIVERIO	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

U937+RA	NULL
B	NULL
cl	NULL
-	NULL
2	NULL
UJ	NULL
3000	NULL
7	NULL
-o	NULL
retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
#	NULL
untreated	NULL
tTG	NULL
``	NULL
tissue	NULL
``	NULL
transglutaminase	NULL
activity	NULL
(	NULL
pmoles/h/mg	NULL
protein	NULL
)	NULL
T	NULL
0	NULL
2	NULL
4	NULL
4	NULL
8	NULL
7	NULL
2	NULL
TIME	NULL
(	NULL
hours	NULL
)	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
RA	NULL
on	NULL
tTG	NULL
and	NULL
Bcl-2	NULL
levels	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Effect	NULL
of	NULL
RA	NULL
on	NULL
Bcel-2	NULL
and	NULL
tTG	NULL
immunostaining	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
on	NULL
slides	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
left	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
right	NULL
)	NULL
of	NULL
RA	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
and	NULL
1.25	NULL
%	NULL
DMSO	NULL
for	NULL
2	NULL
days	NULL
(	NULL
cell	NULL
viability	NULL
was	NULL
reduced	NULL
to	NULL
50	NULL
%	NULL
)	NULL
.	NULL

After	NULL
treatment	NULL
,	NULL
cells	NULL
were	NULL
fixed	NULL
in	NULL
2.5	NULL
%	NULL
paraformaldehyde	NULL
,	NULL
and	NULL
after	NULL
immunostaining	NULL
,	NULL
they	NULL
were	NULL
counterstained	NULL
with	NULL
hematoxylin	NULL
.	NULL

Note	NULL
the	NULL
marked	NULL
bel-2	NULL
downregulation	NULL
highlighted	NULL
by	NULL
the	NULL
pale	NULL
Bel-2	NULL
staining	NULL
in	NULL
RA-treated	NULL
U937	NULL
cells	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
note	NULL
the	NULL
intense	NULL
tTG	NULL
immunoreaction	NULL
in	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
RA	NULL
,	NULL
which	NULL
,	NULL
in	NULL
the	NULL
typical	NULL
apoptotic	NULL
bodies	NULL
,	NULL
is	NULL
localized	NULL
in	NULL
the	NULL
entire	NULL
cell	NULL
,	NULL
including	NULL
the	NULL
nucleus	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

Magnification	NULL
,	NULL
X2,200	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Left	NULL
panel	NULL
,	NULL
U937	NULL
cells	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
with	NULL
1	NULL
uM	NULL
RA	NULL
for	NULL
24	NULL
,	NULL
48	NULL
,	NULL
or	NULL
72	NULL
h.	NULL
Cells	NULL
cultured	NULL
as	NULL
described	NULL
above	NULL
were	NULL
extensively	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
tTG	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
vitro	NULL
as	NULL
picomoles	NULL
of	NULL
[	NULL
*HJputrescine	NULL
incorporated	NULL
into	NULL
protein	NULL
per	NULL
hour	NULL
per	NULL
milligram	NULL
of	NULL
protein	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Data	NULL
are	NULL
the	NULL
means	NULL
+	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
for	NULL
triplicate	NULL
determinations	NULL
in	NULL
three	NULL
different	NULL
experiments	NULL
.	NULL

Right	NULL
panel	NULL
,	NULL
U937	NULL
cells	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
,	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
lane	NULL
C	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
1	NULL
M	NULL
RA	NULL
for	NULL
48	NULL
h	NULL
(	NULL
lane	NULL
RA	NULL
)	NULL
,	NULL
were	NULL
extensively	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

voL	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
TISSUE	NULL
TRANSGLUTAMINASE	NULL
AND	NULL
pRB	NULL
IN	NULL
APOPTOSIS	NULL
-	NULL
6043	NULL
O	NULL
to	NULL
+	NULL
I	NULL
r	NULL
2	NULL
co	NULL
<	NULL
o	NULL
g	NULL
E	NULL
>	NULL
>	NULL
a	NULL
<	NULL
m	NULL
CC	NULL
a.	NULL
iz	NULL
z	NULL
£	NULL
o	NULL
&	NULL
2	NULL
)	NULL
8	NULL
C	NULL
v-	NULL
&	NULL
O	NULL
#	NULL
B	NULL
|	NULL
sate	NULL
1	NULL
3	NULL
7	NULL
pRB	NULL
(	NULL
110	NULL
)	NULL
mie	NULL
hus	NULL
aa	NULL
i	NULL
-v	NULL
|	NULL
WW	NULL
actin	NULL
pRB	NULL
__	NULL
(	NULL
68	NULL
)	NULL
--	NULL
--	NULL
-I	NULL
»	NULL
-|	NULL
wuts	NULL
-	NULL
Alb	NULL
isolated	NULL
tTG	NULL
substrate	NULL
proteins	NULL
©	NULL
|	NULL
cusco	NULL
»	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Characterization	NULL
of	NULL
tTG	NULL
protein	NULL
substrates	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
affinity-purified	NULL
endogenous	NULL
tTG	NULL
substrate	NULL
proteins	NULL
from	NULL
U937	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
treated	NULL
for	NULL
3	NULL
days	NULL
with	NULL
25	NULL
mM	NULL
DALP-methyl	NULL
carbamate-1	NULL
wM	NULL
RA-1.25	NULL
%	NULL
DMSO	NULL
.	NULL

After	NULL
immunopurification	NULL
,	NULL
aliquots	NULL
(	NULL
5	NULL
pg	NULL
of	NULL
total	NULL
protein	NULL
)	NULL
of	NULL
the	NULL
isolated	NULL
tTG	NULL
substrate	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
the	NULL
anti-dinitrophenyl	NULL
and	NULL
the	NULL
C15	NULL
anti-pRB	NULL
MAbs	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cell	NULL
lysates	NULL
obtained	NULL
from	NULL
U937	NULL
cells	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
U937	NULL
)	NULL
(	NULL
10	NULL
pg/m	NULL
!	NULL

1	NULL
)	NULL
or	NULL
purified	NULL
guinea	NULL
pig	NULL
liver	NULL
tTG	NULL
(	NULL
U937	NULL
+	NULL
tTG	NULL
)	NULL
(	NULL
1	NULL
pg/ml	NULL
)	NULL
for	NULL
1	NULL
h.	NULL
After	NULL
incubation	NULL
,	NULL
aliquots	NULL
of	NULL
100	NULL
pg	NULL
of	NULL
total	NULL
protein	NULL
were	NULL
used	NULL
for	NULL
Western	NULL
blot	NULL
analysis	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
with	NULL
the	NULL
C15	NULL
anti-pRB	NULL
MAb	NULL
used	NULL
for	NULL
staining	NULL
.	NULL

Numbers	NULL
on	NULL
the	NULL
left	NULL
in	NULL
cach	NULL
panel	NULL
are	NULL
molecular	NULL
weights	NULL
in	NULL
thousands	NULL
.	NULL

calphostin	NULL
C-induced	NULL
apoptosis	NULL
on	NULL
pRB	NULL
.	NULL

As	NULL
shown	NULL
for	NULL
RA-induced	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
,	NULL
calphostin	NULL
C-induced	NULL
apoptosis	NULL
also	NULL
occurs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increased	NULL
tTG	NULL
activity	NULL
(	NULL
45	NULL
+	NULL
10	NULL
pmol/h/mg	NULL
of	NULL
protein	NULL
in	NULL
untreated	NULL
U937	NULL
cells	NULL
versus	NULL
220	NULL
+	NULL
35	NULL
pmol/h/mg	NULL
of	NULL
protein	NULL
in	NULL
250	NULL
nM	NULL
calphostin	NULL
C-treated	NULL
U937	NULL
cells	NULL
)	NULL
.	NULL

Lysates	NULL
of	NULL
U937	NULL
cells	NULL
treated	NULL
with	NULL
calphostin	NULL
C	NULL
for	NULL
30	NULL
or	NULL
60	NULL
min	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-7.5	NULL
%	NULL
PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
C15	NULL
anti-human	NULL
pRB	NULL
MAb	NULL
.	NULL

In	NULL
untreated	NULL
cells	NULL
(	NULL
maintained	NULL
for	NULL
18	NULL
h	NULL
in	NULL
0.5	NULL
%	NULL
FCS	NULL
)	NULL
this	NULL
antibody	NULL
evidenced	NULL
the	NULL
broad	NULL
band	NULL
in	NULL
the	NULL
105,000-	NULL
to	NULL
110,000-MW	NULL
area	NULL
corresponding	NULL
to	NULL
pRB	NULL
in	NULL
different	NULL
phosphorylation	NULL
states	NULL
together	NULL
with	NULL
the	NULL
Other	NULL
band	NULL
showing	NULL
an	NULL
MW	NULL
of	NULL
68,000	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
calphostin	NULL
C	NULL
brought	NULL
about	NULL
a	NULL
drastic	NULL
modification	NULL
of	NULL
this	NULL
pattern	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
rapid	NULL
disappearance	NULL
of	NULL
all	NULL
of	NULL
the	NULL
pRB-immunopositive	NULL
bands	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
;	NULL
in	NULL
addition	NULL
,	NULL
in	NULL
keeping	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
experiments	NULL
reported	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
the	NULL
smear	NULL
of	NULL
products	NULL
with	NULL
MWs	NULL
higher	NULL
than	NULL
250,000	NULL
was	NULL
also	NULL
detected	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
calphostin	NULL
C	NULL
on	NULL
pRB	NULL
was	NULL
dependent	NULL
on	NULL
tTG	NULL
action	NULL
,	NULL
we	NULL
blocked	NULL
tTG	NULL
activity	NULL
(	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
calphostin	NULL
C	NULL
)	NULL
by	NULL
treating	NULL
U937	NULL
cells	NULL
with	NULL
1	NULL
mM	NULL
dansylcadaverine	NULL
,	NULL
a	NULL
well-known	NULL
tTG	NULL
inhibitor	NULL
(	NULL
15	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
the	NULL
disappearance	NULL
of	NULL
the	NULL
pRB	NULL
105,000-	NULL
to	NULL
110,000-MW	NULL
and	NULL
68,000-MW	NULL
bands	NULL
observed	NULL
in	NULL
calphostin	NULL
C-treated	NULL
cells	NULL
was	NULL
largely	NULL
reduced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dansylcadaverine	NULL
,	NULL
thus	NULL
confirming	NULL
the	NULL
hypothesis	NULL
that	NULL
pRB	NULL
acts	NULL
as	NULL
a	NULL
substrate	NULL
for	NULL
tTG	NULL
in	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
in	NULL
some	NULL
experiments	NULL
,	NULL
calphostin	NULL
C-induced	NULL
disappearance	NULL
of	NULL
the	NULL
pRB	NULL
105,000-	NULL
to	NULL
110,000-MW	NULL
bands	NULL
was	NULL
not	NULL
quantitative	NULL
;	NULL
in	NULL
this	NULL
case	NULL
,	NULL
residual	NULL
pRB	NULL
(	NULL
10	NULL
to	NULL
20	NULL
%	NULL
of	NULL
the	NULL
total	NULL
pRB	NULL
immunostaining	NULL
)	NULL
was	NULL
found	NULL
in	NULL
the	NULL
hypophosphorylated	NULL
form	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
phenomenon	NULL
remains	NULL
to	NULL
be	NULL
better	NULL
investigated	NULL
in	NULL
future	NULL
studies	NULL
,	NULL
at	NULL
present	NULL
one	NULL
could	NULL
entertain	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
hyperphosphorylated	NULL
pRB	NULL
might	NULL
be	NULL
a	NULL
better	NULL
substrate	NULL
for	NULL
the	NULL
tTG	NULL
than	NULL
the	NULL
hypophosphorylated	NULL
counterpart	NULL
.	NULL

The	NULL
phosphorylation	NULL
,	NULL
for	NULL
instance	NULL
,	NULL
could	NULL
modify	NULL
pRB	NULL
folding	NULL
,	NULL
making	NULL
the	NULL
lysine	NULL
and	NULL
glutamine	NULL
residues	NULL
better	NULL
exposed	NULL
on	NULL
the	NULL
surface	NULL
to	NULL
the	NULL
action	NULL
of	NULL
tTG	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
pRB-null	NULL
U937	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
functional	NULL
relationship	NULL
between	NULL
pRB	NULL
and	NULL
tTG	NULL
in	NULL
apoptosis	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
isolate	NULL
U937	NULL
cells	NULL
which	NULL
had	NULL
a	NULL
null	NULL
pRB	NULL
expression	NULL
.	NULL

By	NULL
using	NULL
a	NULL
limiting-dilution	NULL
approach	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
isolated	NULL
several	NULL
clones	NULL
which	NULL
showed	NULL
a	NULL
specific	NULL
reduction	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
pRB	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
no	NULL
significant	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
other	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
be/-2	NULL
and	NULL
the	NULL
6044	NULL
OLIVERIO	NULL
ET	NULL
AL	NULL
.	NULL

a	NULL
125	NULL
7	NULL
[	NULL
J	NULL
Untreated	NULL
1	NULL
hour	NULL
1001	NULL
_	NULL
Q	NULL
3	NULL
hours	NULL
C	NULL
}	NULL
?	NULL

w	NULL
e	NULL
]	NULL
a	NULL
3	NULL
2	NULL
50	NULL
7	NULL
<	NULL
4	NULL
25	NULL
4	NULL
0	NULL
r	NULL
n	NULL
Calphostin	NULL
C	NULL
(	NULL
uM	NULL
)	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Characterization	NULL
of	NULL
apoptosis	NULL
in	NULL
calphostin	NULL
C-treated	NULL
U937	NULL
cells	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Quantitative	NULL
analysis	NULL
of	NULL
the	NULL
time	NULL
course	NULL
effect	NULL
of	NULL
calphostin	NULL
C-induced	NULL
apoptosis	NULL
on	NULL
U937	NULL
cells	NULL
.	NULL

Apoptosis	NULL
was	NULL
analyzed	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
means	NULL
+	NULL
standard	NULL
errors	NULL
of	NULL
the	NULL
means	NULL
for	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Cell	NULL
cycle	NULL
phase	NULL
analysis	NULL
of	NULL
U937	NULL
cells	NULL
maintained	NULL
in	NULL
0.5	NULL
%	NULL
serum	NULL
for	NULL
18	NULL
h	NULL
before	NULL
treatment	NULL
with	NULL
250	NULL
nM	NULL
calphostin	NULL
C	NULL
(	NULL
A	NULL
)	NULL
or	NULL
after	NULL
drug	NULL
treatment	NULL
for	NULL
1	NULL
h	NULL
(	NULL
B	NULL
)	NULL
or	NULL
3	NULL
h	NULL
(	NULL
C	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
and	NULL
apoptosis	NULL
were	NULL
analyzed	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
axes	NULL
represent	NULL
580-nm	NULL
fluorescence	NULL
emission	NULL
by	NULL
propidium	NULL
iodide	NULL
(	NULL
x	NULL
)	NULL
and	NULL
number	NULL
of	NULL
events	NULL
(	NULL
y	NULL
)	NULL
.	NULL

Note	NULL
the	NULL
time-dependent	NULL
increase	NULL
in	NULL
the	NULL
number	NULL
of	NULL
calphostin-C-treated	NULL
U937	NULL
cells	NULL
detected	NULL
as	NULL
apoptotic	NULL
with	NULL
the	NULL
respect	NULL
to	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
and	NULL
S/G	NULL
phases	NULL
.	NULL

mitogen-activated	NULL
protein	NULL
kinase	NULL
gene	NULL
,	NULL
or	NULL
in	NULL
basal	NULL
tTG	NULL
activity	NULL
were	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

The	NULL
data	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
indicate	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
pRB	NULL
expression	NULL
observed	NULL
in	NULL
the	NULL
U937	NULL
clones	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
net	NULL
decrease	NULL
in	NULL
the	NULL
sensitivity	NULL
to	NULL
apoptotic	NULL
stimuli	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
pRB-null	NULL
cells	NULL
were	NULL
much	NULL
less	NULL
prone	NULL
to	NULL
apoptosis	NULL
induction	NULL
elicited	NULL
by	NULL
growth	NULL
factor	NULL
withdrawal	NULL
,	NULL
C6-ceramide	NULL
,	NULL
and	NULL
calphostin	NULL
C	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
when	NULL
we	NULL
tested	NULL
the	NULL
effect	NULL
of	NULL
calphostin	NULL
C-induced	NULL
apoptosis	NULL
on	NULL
pRB-null	NULL
clones	NULL
,	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
pRB-immunopositive	NULL
products	NULL
with	NULL
MWs	NULL
higher	NULL
than	NULL
250,000	NULL
that	NULL
we	NULL
detected	NULL
in	NULL
U937	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

Effect	NULL
on	NULL
E2F-1	NULL
of	NULL
calphostin	NULL
C-dependent	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

The	NULL
E2F-1	NULL
transcription	NULL
factor	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
progression	NULL
at	NULL
the	NULL
G	NULL
,	NULL
-S	NULL
transition	NULL
and	NULL
apoptosis	NULL
(	NULL
18	NULL
,	NULL
20	NULL
,	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
that	NULL
E2F-1	NULL
is	NULL
actively	NULL
degraded	NULL
by	NULL
the	NULL
ubiquitin	NULL
(	NULL
Ub	NULL
)	NULL
-proteasome	NULL
pathway	NULL
and	NULL
that	NULL
the	NULL
binding	NULL
to	NULL
pRB	NULL
stabilizes	NULL
E2F-1	NULL
against	NULL
in	NULL
vivo	NULL
degradation	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
get	NULL
information	NULL
on	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
pRB	NULL
during	NULL
calphostin	NULL
C-induced	NULL
apoptosis	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
this	NULL
protein	NULL
kinase	NULL
C	NULL
inhibitor	NULL
on	NULL
E2F-1	NULL
protein	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Lysates	NULL
of	NULL
U937	NULL
cells	NULL
maintained	NULL
in	NULL
0.5	NULL
%	NULL
serum	NULL
and	NULL
treated	NULL
with	NULL
calphostin	NULL
C	NULL
for	NULL
30	NULL
or	NULL
60	NULL
min	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotted	NULL
with	NULL
anti-human	NULL
E2F-1	NULL
(	NULL
epitope	NULL
corresponding	NULL
to	NULL
amino	NULL
acids	NULL
418	NULL
to	NULL
437	NULL
)	NULL
.	NULL

In	NULL
control	NULL
cells	NULL
,	NULL
this	NULL
antibody	NULL
evidenced	NULL
a	NULL
band	NULL
showing	NULL
an	NULL
MW	NULL
of	NULL
about	NULL
60,000	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
cells	NULL
with	NULL
calphostin	NULL
C	NULL
brought	NULL
about	NULL
a	NULL
rapid	NULL
modification	NULL
of	NULL
this	NULL
pattern	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
disappearance	NULL
of	NULL
the	NULL
E2F-1-immunopositive	NULL
band	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
thus	NULL
suggesting	NULL
a	NULL
rapid	NULL
degradation	NULL
by	NULL
the	NULL
Ub-proteasome	NULL
pathway	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

S	NULL
--	NULL
e	NULL
197	NULL
104	NULL
1	NULL
@	NULL
4	NULL
DISCUSSION	NULL
The	NULL
tTG	NULL
gene	NULL
is	NULL
induced	NULL
in	NULL
dying	NULL
cells	NULL
under	NULL
physiological	NULL
and	NULL
pathological	NULL
conditions	NULL
in	NULL
vivo	NULL
as	NULL
well	NULL
as	NULL
in	NULL
several	NULL
in	NULL
vitro	NULL
contexts	NULL
(	NULL
2	NULL
,	NULL
10	NULL
,	NULL
25	NULL
,	NULL
30	NULL
,	NULL
39	NULL
)	NULL
.	NULL

A	NULL
definitive	NULL
role	NULL
for	NULL
tTG	NULL
in	NULL
apoptosis	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
firmly	NULL
established	NULL
;	NULL
however	NULL
,	NULL
tTG	NULL
ex	NULL
Vou	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
TISSUE	NULL
TRANSGLUTAMINASE	NULL
AND	NULL
pRB	NULL
IN	NULL
APOPTOSIS	NULL
-	NULL
6045	NULL
A	NULL
Calphostin	NULL
C	NULL
(	NULL
min	NULL
)	NULL
30	NULL
30	NULL
60	NULL
``	NULL
~	NULL
M	NULL
#	NULL
26	NULL
RB	NULL
_	NULL
(	NULL
110	NULL
'm	NULL
*	NULL
RB	NULL
68	NULL
--	NULL
p	NULL
0	NULL
st	NULL
3	NULL
0	NULL
M	NULL
a	NULL
C	NULL
C	NULL
0	NULL
G	NULL
i	NULL
.	NULL

0	NULL
13	NULL
=	NULL
3	NULL
w	NULL
cC	NULL
©	NULL
o	NULL
hy	NULL
per	NULL
|	NULL
pre	NULL
gH	NULL
bull	NULL
blk	NULL
iss	NULL
)	NULL
._	NULL
--	NULL
-	NULL
10	NULL
20	NULL
30	NULL
Calphostin	NULL
C	NULL
10	NULL
%	NULL
FCS	NULL
0.5	NULL
%	NULL
FCS	NULL
(	NULL
min	NULL
)	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
calphostin	NULL
C	NULL
on	NULL
pRB	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cell	NULL
lysates	NULL
obtained	NULL
from	NULL
U937	NULL
cells	NULL
maintained	NULL
for	NULL
18	NULL
h	NULL
in	NULL
0.5	NULL
%	NULL
FCS	NULL
and	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
30	NULL
min	NULL
(	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
1	NULL
mM	NULL
dansyleadaverine	NULL
)	NULL
or	NULL
60	NULL
min	NULL
with	NULL
250	NULL
nM	NULL
calphostin	NULL
C.	NULL
Numbers	NULL
on	NULL
the	NULL
left	NULL
are	NULL
molecular	NULL
weights	NULL
in	NULL
thousands	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cells	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
were	NULL
shifted	NULL
to	NULL
0.5	NULL
%	NULL
FCS	NULL
for	NULL
18	NULL
h	NULL
and	NULL
either	NULL
left	NULL
untreated	NULL
or	NULL
treated	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
with	NULL
250	NULL
nM	NULL
calphostin	NULL
C.	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
SDS-12.5	NULL
%	NULL
PAGE	NULL
for	NULL
protein	NULL
separation	NULL
and	NULL
the	NULL
anti-pRB	NULL
MAbs	NULL
against	NULL
amino	NULL
acids	NULL
619	NULL
to	NULL
928	NULL
for	NULL
staining	NULL
the	NULL
immunoblot	NULL
.	NULL

pression	NULL
is	NULL
not	NULL
a	NULL
late	NULL
epiphenomenon	NULL
,	NULL
since	NULL
antisense	NULL
tTG	NULL
transfection	NULL
did	NULL
not	NULL
affect	NULL
disposal	NULL
and	NULL
degradation	NULL
of	NULL
(	NULL
poorly	NULL
cross-linked	NULL
)	NULL
apoptotic	NULL
bodies	NULL
but	NULL
actually	NULL
reduced	NULL
apoptosis	NULL
30	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
y	NULL
using	NULL
various	NULL
experimental	NULL
approaches	NULL
,	NULL
we	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
in	NULL
U937	NULL
cells	NULL
the	NULL
polymerization	NULL
of	NULL
pRB	NULL
,	NULL
which	NULL
precedes	NULL
apoptosis	NULL
,	NULL
is	NULL
mediated	NULL
by	NULL
its	NULL
posttranslational	NULL
modification	NULL
catalyzed	NULL
by	NULL
tTG	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
in	NULL
these	NULL
p53-null	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
pRB	NULL
largely	NULL
increases	NULL
the	NULL
resistance	NULL
to	NULL
apoptosis	NULL
induced	NULL
by	NULL
different	NULL
stimuli	NULL
.	NULL

Previous	NULL
studies	NULL
suggested	NULL
that	NULL
an	NULL
extensive	NULL
tTG	NULL
activation	NULL
leads	NULL
to	NULL
the	NULL
assembly	NULL
of	NULL
intracellular	NULL
cross-linked	NULL
protein	NULL
poly-mers	NULL
,	NULL
which	NULL
irreversibly	NULL
modifies	NULL
the	NULL
cell	NULL
organization	NULL
,	NULL
contributing	NULL
to	NULL
the	NULL
widespread	NULL
,	NULL
ultrastructural	NULL
changes	NULL
occurring	NULL
in	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
(	NULL
10	NULL
,	NULL
11	NULL
,	NULL
25	NULL
)	NULL
.	NULL

This	NULL
extensive	NULL
tTG-dependent	NULL
protein	NULL
polymerization	NULL
stabilizes	NULL
apoptotic	NULL
cells	NULL
be	NULL
fore	NULL
their	NULL
clearance	NULL
by	NULL
phagocytosis	NULL
,	NULL
thus	NULL
contributing	NULL
to	NULL
the	NULL
prevention	NULL
of	NULL
inflammation	NULL
in	NULL
the	NULL
surrounding	NULL
tissues	NULL
(	NULL
3	NULL
,	NULL
11	NULL
,	NULL
17	NULL
,	NULL
38	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
question	NULL
arises	NULL
as	NULL
to	NULL
whether	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
the	NULL
death	NULL
pathway	NULL
,	NULL
a	NULL
regulated	NULL
tTG-mediated	NULL
posttranslational	NULL
modification	NULL
of	NULL
a	NULL
specific	NULL
protein	NULL
substrate	NULL
(	NULL
s	NULL
)	NULL
might	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
commitment	NULL
to	NULL
apoptosis	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
this	NULL
hypothesis	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
during	NULL
the	NULL
early	NULL
phases	NULL
of	NULL
apoptosis	NULL
,	NULL
tTG	NULL
posttranslationally	NULL
modifies	NULL
pRB	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
this	NULL
cross-linking	NULL
enzyme	NULL
might	NULL
determine	NULL
an	NULL
irreversible	NULL
commitment	NULL
to	NULL
death	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
pRB	NULL
polymerization	NULL
was	NULL
already	NULL
detectable	NULL
after	NULL
10	NULL
to	NULL
20	NULL
min	NULL
in	NULL
calphostin	NULL
C-treated	NULL
U937	NULL
cells	NULL
,	NULL
when	NULL
the	NULL
level	NULL
of	NULL
apoptosis	NULL
was	NULL
still	NULL
unchanged	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

pRB	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
cell	NULL
cycle	NULL
control	NULL
(	NULL
7	NULL
,	NULL
43	NULL
)	NULL
.	NULL

It	NULL
is	NULL
generally	NULL
accepted	NULL
that	NULL
pRB	NULL
,	NULL
in	NULL
the	NULL
hypophosphorylated	NULL
state	NULL
,	NULL
binds	NULL
to	NULL
and	NULL
impairs	NULL
the	NULL
activities	NULL
of	NULL
several	NULL
proteins	NULL
,	NULL
including	NULL
6046	NULL
OLIVERIO	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

CLONES	NULL
rm	NULL
&	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
60	NULL
S	NULL
137	NULL
--	NULL
»	NULL
<	NULL
=	NULL
mig	NULL
x	NULL
!	NULL

.	NULL

,	NULL
pRB	NULL
32	NULL
--	NULL
*	NULL
27	NULL
--	NULL
_|	NULL
&	NULL
»	NULL
tun	NULL
***	NULL
aus	NULL
at	NULL
A|	NULL
A-	NULL
Bcl-2	NULL
44	NULL
--	NULL
-	NULL
#	NULL
emmm	NULL
|	NULL
<	NULL
--	NULL
MAP	NULL
_kinase	NULL
32	NULL
--	NULL
*	NULL
50	NULL
70	NULL
55	NULL
65	NULL
60	NULL
45	NULL
45	NULL
tTG	NULL
-	NULL
activity	NULL
(	NULL
pmoles/h/mg	NULL
protein	NULL
)	NULL
U937	NULL
Clone	NULL
2	NULL
B	NULL
a-	NULL
‘	NULL
``	NULL
``	NULL
~	NULL
.	NULL

ge-	NULL
,	NULL
pRB	NULL
(	NULL
110	NULL
)	NULL
--	NULL
-	NULL
>	NULL
|	NULL
«	NULL
mms	NULL
RB	NULL
(	NULL
68	NULL
--	NULL
-I	NULL
»	NULL
|	NULL
onium	NULL
“	NULL
|	NULL
comm	NULL
0	NULL
-	NULL
60	NULL
0	NULL
-	NULL
60	NULL
Calph	NULL
C_	NULL
Calph	NULL
C	NULL
(	NULL
min	NULL
.	NULL
)	NULL

(	NULL
min	NULL
.	NULL
)	NULL

FIG	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
calphostin	NULL
C	NULL
on	NULL
U937-derived	NULL
pRB-null	NULL
clones	NULL
.	NULL

(	NULL
A	NULL
)	NULL
U937	NULL
cells	NULL
and	NULL
derived	NULL
pRB-null	NULL
clones	NULL
were	NULL
grown	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

After	NULL
extensive	NULL
washings	NULL
in	NULL
PBS	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cell	NULL
lysates	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
anti-pRB	NULL
,	NULL
-Bcl-2	NULL
,	NULL
and	NULL
-mitogen-activated	NULL
protein	NULL
kinase	NULL
MAbs	NULL
on	NULL
100	NULL
pg	NULL
of	NULL
total	NULL
protein	NULL
.	NULL

tTG	NULL
activity	NULL
of	NULL
the	NULL
U937	NULL
cell	NULL
clones	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cell	NULL
lysates	NULL
obtained	NULL
from	NULL
U937	NULL
cells	NULL
and	NULL
the	NULL
derived	NULL
pRB-null	NULL
clones	NULL
.	NULL

Cells	NULL
maintained	NULL
for	NULL
18	NULL
h	NULL
in	NULL
0.5	NULL
%	NULL
FCS	NULL
were	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
0	NULL
min	NULL
)	NULL
or	NULL
treated	NULL
for	NULL
60	NULL
min	NULL
with	NULL
250	NULL
nM	NULL
calphostin	NULL
.	NULL

Numbers	NULL
on	NULL
the	NULL
left	NULL
in	NULL
each	NULL
panel	NULL
are	NULL
molecular	NULL
weights	NULL
in	NULL
thousands	NULL
.	NULL

the	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
E2F	NULL
family	NULL
(	NULL
7	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
range	NULL
of	NULL
pRB	NULL
functions	NULL
has	NULL
recently	NULL
been	NULL
discovered	NULL
to	NULL
be	NULL
more	NULL
com-plex	NULL
,	NULL
since	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
functional	NULL
pRB	NULL
may	NULL
result	NULL
in	NULL
apoptosis	NULL
rather	NULL
than	NULL
in	NULL
uncontrolled	NULL
cell	NULL
proliferation	NULL
(	NULL
1	NULL
,	NULL
32	NULL
,	NULL
42	NULL
)	NULL
and	NULL
that	NULL
overexpression	NULL
of	NULL
functional	NULL
pRB	NULL
may	NULL
induce	NULL
apoptosis	NULL
or	NULL
rescue	NULL
cells	NULL
from	NULL
death	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
system	NULL
(	NULL
16	NULL
,	NULL
29	NULL
,	NULL
46	NULL
)	NULL
.	NULL

Homozygous	NULL
pRB-null	NULL
mice	NULL
die	NULL
during	NULL
gestation	NULL
,	NULL
showing	NULL
massive	NULL
induction	NULL
of	NULL
apoptosis	NULL
dur-	NULL
voL	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
TABLE	NULL
1	NULL
.	NULL

Effect	NULL
of	NULL
serum	NULL
,	NULL
calphostin	NULL
C	NULL
,	NULL
and	NULL
C6-ceramide	NULL
on	NULL
apoptosis	NULL
in	NULL
pRB-null	NULL
U937-derived	NULL
cell	NULL
clones	NULL
``	NULL
%	NULL
Apoptosis	NULL
(	NULL
mean	NULL
+	NULL
SEM	NULL
[	NULL
n	NULL
=	NULL
3	NULL
]	NULL
)	NULL
in	NULL
:	NULL
Treatment	NULL
U937	NULL
Clone	NULL
2	NULL
Clone	NULL
3	NULL
FCS	NULL
(	NULL
10.0	NULL
%	NULL
)	NULL
7.7	NULL
*	NULL
#	NULL
1.5	NULL
4.2	NULL
+	NULL
2.0	NULL
5.4	NULL
#	NULL
1.1	NULL
FCS	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
24.3	NULL
+	NULL
4.0	NULL
13.2	NULL
+	NULL
3.0	NULL
12.7	NULL
+	NULL
3.5	NULL
Calphostin	NULL
C	NULL
(	NULL
250	NULL
nM	NULL
)	NULL
75.3	NULL
+	NULL
14.0	NULL
25.2	NULL
+	NULL
3.0	NULL
27.7	NULL
+	NULL
3.5	NULL
C6-Ceramide	NULL
(	NULL
30	NULL
HM	NULL
)	NULL
54.3	NULL
+	NULL
9.0	NULL
23.0	NULL
+	NULL
3.0	NULL
29.7	NULL
+	NULL
6.5	NULL
*	NULL
Apoptosis	NULL
in	NULL
cells	NULL
growing	NULL
in	NULL
10	NULL
%	NULL
FCS	NULL
as	NULL
well	NULL
as	NULL
after	NULL
a	NULL
shift	NULL
to	NULL
0.5	NULL
%	NULL
FCS	NULL
for	NULL
18	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
treatment	NULL
or	NULL
after	NULL
a	NULL
3-h	NULL
exposure	NULL
to	NULL
calphostin	NULL
C	NULL
or	NULL
C6-ceramide	NULL
at	NULL
the	NULL
incated	NULL
concentration	NULL
was	NULL
evaluated	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
extensively	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
percentage	NULL
of	NULL
apoptotic	NULL
cells	NULL
was	NULL
evaluated	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
analysis	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

ing	NULL
liver	NULL
erythropoiesis	NULL
and	NULL
neuronal	NULL
development	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
question	NULL
arises	NULL
as	NULL
to	NULL
the	NULL
functional	NULL
implications	NULL
of	NULL
the	NULL
tTG-dependent	NULL
polymerization	NULL
of	NULL
pRB	NULL
occurring	NULL
during	NULL
the	NULL
early	NULL
phases	NULL
of	NULL
apoptosis	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
pRB	NULL
polymerization	NULL
might	NULL
lead	NULL
to	NULL
its	NULL
functional	NULL
inactivation	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
the	NULL
tTG-dependent	NULL
polymerization	NULL
of	NULL
pRB	NULL
is	NULL
paralleled	NULL
by	NULL
the	NULL
rapid	NULL
disappearance	NULL
of	NULL
E2F-1	NULL
,	NULL
which	NULL
occurs	NULL
when	NULL
the	NULL
transcription	NULL
factor	NULL
is	NULL
not	NULL
protected	NULL
by	NULL
pRB	NULL
binding	NULL
from	NULL
entering	NULL
the	NULL
Ub-proteasome	NULL
pathway	NULL
(	NULL
18	NULL
,	NULL
20	NULL
)	NULL
.	NULL

U937	NULL
cells	NULL
provide	NULL
a	NULL
p53-null	NULL
line	NULL
(	NULL
reference	NULL
26	NULL
and	NULL
our	NULL
unpublished	NULL
observations	NULL
)	NULL
,	NULL
leading	NULL
to	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
loss	NULL
of	NULL
pRB	NULL
function	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
occurrence	NULL
of	NULL
apoptosis	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
simultaneous	NULL
absence	NULL
of	NULL
pRB	NULL
and	NULL
p53	NULL
is	NULL
not	NULL
incompatible	NULL
with	NULL
life	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
we	NULL
have	NULL
showed	NULL
here	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
pRB	NULL
leads	NULL
to	NULL
a	NULL
an	NULL
increased	NULL
resistance	NULL
to	NULL
several	NULL
apoptotic	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
growth	NULL
factor	NULL
deprivation	NULL
and	NULL
calphostin	NULL
C	NULL
and	NULL
C6é-ceramide	NULL
treatment	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
polymerization	NULL
of	NULL
pRB	NULL
observed	NULL
in	NULL
U937	NULL
cells	NULL
might	NULL
represent	NULL
a	NULL
key	NULL
signal	NULL
for	NULL
the	NULL
initiation	NULL
of	NULL
apoptosis	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
pRB	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
p53	NULL
,	NULL
may	NULL
have	NULL
dramatic	NULL
consequence	NULL
for	NULL
cycling	NULL
cells	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
as	NULL
we	NULL
observed	NULL
for	NULL
the	NULL
U937-derived	NULL
pRB-null	NULL
cell	NULL
clones	NULL
,	NULL
this	NULL
condition	NULL
results	NULL
in	NULL
83	NULL
--	NULL
»	NULL
serem	NULL
ag	NULL
_-	NULL
E2F	NULL
-	NULL
!	NULL

44	NULL
-P	NULL
0	NULL
30	NULL
60	NULL
Calph	NULL
C	NULL
(	NULL
min	NULL
.	NULL
)	NULL

FIG	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
calphostin	NULL
C	NULL
on	NULL
E2F-1	NULL
levels	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
,	NULL
with	NULL
the	NULL
anti-human	NULL
E2F-1	NULL
MAb	NULL
,	NULL
of	NULL
lysates	NULL
obtained	NULL
from	NULL
U937	NULL
cells	NULL
maintained	NULL
for	NULL
18	NULL
h	NULL
in	NULL
0.5	NULL
%	NULL
FCS	NULL
and	NULL
either	NULL
left	NULL
untreated	NULL
(	NULL
0	NULL
min	NULL
)	NULL
or	NULL
treated	NULL
for	NULL
30	NULL
or	NULL
60	NULL
min	NULL
with	NULL
250	NULL
nM	NULL
calphostin	NULL
C	NULL
is	NULL
shown	NULL
.	NULL

Numbers	NULL
on	NULL
the	NULL
left	NULL
are	NULL
molecular	NULL
weights	NULL
in	NULL
thousands	NULL
.	NULL

TISSUE	NULL
TRANSGLUTAMINASE	NULL
AND	NULL
pRB	NULL
IN	NULL
APOPTOSIS	NULL
-	NULL
6047	NULL
uncontrolled	NULL
proliferation	NULL
associated	NULL
with	NULL
a	NULL
high	NULL
resistance	NULL
to	NULL
apoptosis	NULL
(	NULL
44	NULL
)	NULL
.	NULL

It	NULL
is	NULL
now	NULL
becoming	NULL
clear	NULL
that	NULL
in	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
,	NULL
a	NULL
set	NULL
of	NULL
specific	NULL
proteins	NULL
are	NULL
degraded	NULL
mainly	NULL
by	NULL
the	NULL
caspase	NULL
family	NULL
of	NULL
proteases	NULL
(	NULL
27	NULL
)	NULL
.	NULL

It	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
that	NULL
pRB	NULL
also	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
interleukin-converting	NULL
enzyme-like	NULL
proteases	NULL
in	NULL
the	NULL
context	NULL
of	NULL
apoptosis	NULL
induced	NULL
by	NULL
certain	NULL
antitumor	NULL
drugs	NULL
(	NULL
5	NULL
,	NULL
22	NULL
)	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
several	NULL
substrates	NULL
for	NULL
the	NULL
caspases	NULL
(	NULL
27	NULL
)	NULL
are	NULL
also	NULL
substrates	NULL
for	NULL
tTG	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
pRB	NULL
,	NULL
actin	NULL
(	NULL
25	NULL
,	NULL
35	NULL
)	NULL
and	NULL
histones	NULL
(	NULL
4	NULL
)	NULL
are	NULL
posttranslationally	NULL
modified	NULL
in	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
induced	NULL
by	NULL
both	NULL
tTG	NULL
and	NULL
caspases	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
and	NULL
the	NULL
reciprocal	NULL
influence	NULL
of	NULL
these	NULL
two	NULL
events	NULL
in	NULL
the	NULL
commitment	NULL
to	NULL
and	NULL
execution	NULL
of	NULL
apoptosis	NULL
are	NULL
interesting	NULL
matters	NULL
for	NULL
future	NULL
studies	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
the	NULL
data	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
seem	NULL
to	NULL
indicate	NULL
that	NULL
tTG	NULL
might	NULL
have	NULL
more	NULL
than	NULL
one	NULL
function	NULL
within	NULL
the	NULL
cascade	NULL
of	NULL
events	NULL
leading	NULL
to	NULL
the	NULL
establishment	NULL
of	NULL
the	NULL
apoptotic	NULL
phenotype	NULL
:	NULL
(	NULL
i	NULL
)	NULL
an	NULL
early	NULL
regulatory	NULL
function	NULL
which	NULL
,	NULL
through	NULL
the	NULL
polymerization	NULL
of	NULL
pRB	NULL
,	NULL
may	NULL
influence	NULL
the	NULL
decision	NULL
to	NULL
undergo	NULL
apoptosis	NULL
or	NULL
to	NULL
survive	NULL
,	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
a	NULL
late	NULL
effect	NULL
leading	NULL
to	NULL
the	NULL
stabilization	NULL
of	NULL
the	NULL
dying	NULL
cells	NULL
by	NULL
the	NULL
formation	NULL
of	NULL
intracellular	NULL
cross-linked	NULL
protein	NULL
polymers	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Recent	NULL
experiments	NULL
have	NULL
suggested	NULL
that	NULL
cells	NULL
may	NULL
undergo	NULL
a	NULL
process	NULL
morphologically	NULL
similar	NULL
to	NULL
apoptosis	NULL
without	NULL
a	NULL
nucleus	NULL
and	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
by	NULL
simply	NULL
activating	NULL
the	NULL
downstream	NULL
elements	NULL
(	NULL
17	NULL
,	NULL
21	NULL
)	NULL
,	NULL
thus	NULL
suggesting	NULL
that	NULL
all	NULL
machinery	NULL
is	NULL
already	NULL
in	NULL
place	NULL
before	NULL
the	NULL
apoptotic	NULL
signal	NULL
and	NULL
that	NULL
,	NULL
at	NULL
least	NULL
in	NULL
some	NULL
circumstances	NULL
,	NULL
the	NULL
final	NULL
events	NULL
of	NULL
apoptosis	NULL
may	NULL
be	NULL
controlled	NULL
at	NULL
the	NULL
posttranslational	NULL
level	NULL
.	NULL

The	NULL
plasticity	NULL
provided	NULL
by	NULL
a	NULL
multifunctional	NULL
enzyme	NULL
like	NULL
tTG	NULL
represents	NULL
an	NULL
interesting	NULL
example	NULL
of	NULL
how	NULL
a	NULL
complex	NULL
phenomenon	NULL
such	NULL
as	NULL
apoptosis	NULL
may	NULL
be	NULL
regulated	NULL
at	NULL
the	NULL
posttranslational	NULL
level	NULL
.	NULL

The	NULL
modulation	NULL
of	NULL
the	NULL
tTG	NULL
activity	NULL
or	NULL
G	NULL
,	NULL
,	NULL
,	NULL
protein	NULL
functions	NULL
by	NULL
the	NULL
intracellular	NULL
environment	NULL
(	NULL
such	NULL
as	NULL
the	NULL
levels	NULL
of	NULL
GTP	NULL
,	NULL
Ca**	NULL
,	NULL
and	NULL
free	NULL
di-	NULL
and	NULL
polyamines	NULL
)	NULL
may	NULL
have	NULL
a	NULL
relevant	NULL
role	NULL
in	NULL
the	NULL
decision	NULL
of	NULL
cells	NULL
to	NULL
survive	NULL
or	NULL
die	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
P.	NULL
Luly	NULL
,	NULL
F.	NULL
Autuori	NULL
,	NULL
and	NULL
S.	NULL
Rufini	NULL
for	NULL
stimulating	NULL
discussions	NULL
and	NULL
encouragement	NULL
.	NULL

This	NULL
work	NULL
was	NULL
partially	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
AIRC	NULL
,	NULL
``	NULL
AIDS	NULL
``	NULL
Project	NULL
from	NULL
Ministero	NULL
Sanita	NULL
(	NULL
to	NULL
M.P	NULL
.	NULL
)	NULL

,	NULL
UE	NULL
``	NULL
Biotechnology	NULL
,	NULL
``	NULL
and	NULL
C.N.R	NULL
.	NULL

$	NULL
.0	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
an	NULL
AIRC	NULL
grant	NULL
.	NULL

Angelo	NULL
Spinedi	NULL
and	NULL
Mauro	NULL
Piacentini	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
paper	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Almasan	NULL
,	NULL
A.	NULL
,	NULL
Y.	NULL
Yin	NULL
,	NULL
R.	NULL
E.	NULL
K.	NULL
Lee	NULL
,	NULL
A.	NULL
Bradley	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
J.	NULL
R.	NULL
Bertino	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Wahl	NULL
.	NULL

1995	NULL
.	NULL

Deficiency	NULL
of	NULL
retinoblastoma	NULL
protein	NULL
leads	NULL
to	NULL
inappropriate	NULL
S-phase	NULL
entry	NULL
,	NULL
activation	NULL
of	NULL
E2F-responsive	NULL
genes	NULL
,	NULL
and	NULL
apoptosis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:5436-5440	NULL
.	NULL

2	NULL
.	NULL

Amendola	NULL
,	NULL
A.	NULL
,	NULL
M.-L.	NULL
Gougeon	NULL
,	NULL
F.	NULL
Poccia	NULL
,	NULL
A.	NULL
Bondurand	NULL
,	NULL
L.	NULL
Fesus	NULL
,	NULL
and	NULL
M.	NULL
Piacentini	NULL
.	NULL

1996	NULL
.	NULL

Induction	NULL
of	NULL
``	NULL
tissue	NULL
``	NULL
transglutaminase	NULL
in	NULL
HIV-pathogen-esis	NULL
:	NULL
evidence	NULL
for	NULL
high	NULL
rate	NULL
of	NULL
apoptosis	NULL
of	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
and	NULL
accessory	NULL
cells	NULL
in	NULL
lymphoid	NULL
tissues	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:11057-11062	NULL
.	NULL

3	NULL
.	NULL

Arends	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
H.	NULL
Wyllie	NULL
.	NULL

1991	NULL
.	NULL

Apoptosis	NULL
.	NULL

Mechanism	NULL
and	NULL
role	NULL
in	NULL
pathology	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Exp	NULL
.	NULL

Pathol	NULL
.	NULL

32:223-254	NULL
.	NULL

4	NULL
.	NULL

Ballesteras	NULL
,	NULL
E.	NULL
,	NULL
C.	NULL
Abad	NULL
,	NULL
and	NULL
L.	NULL
Franco	NULL
.	NULL

1996	NULL
.	NULL

Core	NULL
histones	NULL
are	NULL
glutaminyl	NULL
substrates	NULL
for	NULL
tissue	NULL
transglutaminase	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:18817-18824	NULL
.	NULL

5	NULL
.	NULL

Bing	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Q.	NULL
P.	NULL
Dou	NULL
.	NULL

1996	NULL
.	NULL

Cleavage	NULL
of	NULL
retinoblastoma	NULL
protein	NULL
during	NULL
apoptosis	NULL
:	NULL
an	NULL
interleukin	NULL
1b-converting	NULL
enzyme-like	NULL
protease	NULL
as	NULL
candidate	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

56:438-442	NULL
.	NULL

6	NULL
.	NULL

Bruns	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
F.	NULL
D.	NULL
Miller	NULL
,	NULL
R.	NULL
L.	NULL
Merruman	NULL
,	NULL
J.	NULL
J.	NULL
Howbert	NULL
,	NULL
W.	NULL
H.	NULL
Heath	NULL
,	NULL
E.	NULL
Kobayashi	NULL
,	NULL
I.	NULL
Takahashi	NULL
,	NULL
T.	NULL
T	NULL
:	NULL
ki	NULL
,	NULL
and	NULL
H.	NULL
Nak	NULL
1991	NULL
.	NULL

Inhibition	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
by	NULL
calphostin	NULL
C	NULL
is	NULL
light-dependent	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

176:288-293	NULL
.	NULL

7	NULL
.	NULL

DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
J.	NULL
W.	NULL
Ludlow	NULL
,	NULL
L.	NULL
Dennis	NULL
,	NULL
Y.	NULL
Furukawa	NULL
,	NULL
J.	NULL
Griffin	NULL
,	NULL
S.	NULL
Pi-wnica-Worms	NULL
,	NULL
H.	NULL
Huang	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Livingstone	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
product	NULL
of	NULL
the	NULL
retinoblastoma	NULL
susceptibility	NULL
gene	NULL
has	NULL
properties	NULL
of	NULL
a	NULL
cell	NULL
cycle	NULL
regulatory	NULL
clement	NULL
.	NULL

Cell	NULL
58:1085-1095	NULL
.	NULL

6048	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

OLIVERIO	NULL
ET	NULL
AL	NULL
.	NULL

.	NULL

Ellis	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
J.	NULL
Yuan	NULL
,	NULL
and	NULL
H.	NULL
R.	NULL
Horvitz	NULL
.	NULL

1991	NULL
.	NULL

Mechanism	NULL
and	NULL
functions	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

7:663-698.	NULL
.	NULL

Fesus	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
G.	NULL
Arato	NULL
.	NULL

1986	NULL
.	NULL

Quantitation	NULL
of	NULL
tissue	NULL
transglutaminase	NULL
by	NULL
a	NULL
sandwich	NULL
ELISA	NULL
system	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
94:131-138	NULL
.	NULL

Fesus	NULL
,	NULL
L.	NULL
,	NULL
V.	NULL
Thomazy	NULL
,	NULL
and	NULL
A.	NULL
Falus	NULL
.	NULL

1987	NULL
.	NULL

Induction	NULL
and	NULL
activation	NULL
of	NULL
tissue	NULL
transglutaminase	NULL
during	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

224:104-108	NULL
.	NULL

Fesus	NULL
,	NULL
L.	NULL
,	NULL
V.	NULL
Thomazy	NULL
,	NULL
F.	NULL
Autuori	NULL
,	NULL
M.	NULL
P.	NULL
Cera	NULL
,	NULL
E.	NULL
Tarcsa	NULL
,	NULL
and	NULL
M.	NULL
Piacentini	NULL
.	NULL

1989	NULL
.	NULL

Apoptotic	NULL
hepatocytes	NULL
become	NULL
insoluble	NULL
in	NULL
detergents	NULL
and	NULL
chaotropic	NULL
agents	NULL
as	NULL
a	NULL
result	NULL
of	NULL
transglutaminase	NULL
action	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

245:150-154	NULL
.	NULL

Fesus	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

A.	NULL
Davies	NULL
,	NULL
and	NULL
M.	NULL
Piacentini	NULL
.	NULL

1991	NULL
.	NULL

Apoptosis	NULL
:	NULL
molecular	NULL
mechanisms	NULL
in	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

56:170-177	NULL
.	NULL

Folk	NULL
,	NULL
J.	NULL
E.	NULL
1980	NULL
.	NULL

Transglutaminases	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

49:517-531	NULL
.	NULL

Gentile	NULL
,	NULL
V.	NULL
,	NULL
V.	NULL
Thomazy	NULL
,	NULL
M.	NULL
Piacentini	NULL
,	NULL
L.	NULL
Fesus	NULL
,	NULL
and	NULL
P.	NULL
J	NULL
.	NULL

A.	NULL
Davies	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
of	NULL
tissue	NULL
transglutaminase	NULL
in	NULL
BALB-C	NULL
3T3	NULL
fibroblasts	NULL
:	NULL
effects	NULL
on	NULL
cellular	NULL
morphology	NULL
and	NULL
adhesion	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

119:463-474	NULL
.	NULL

Greenberg	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
P.	NULL
J.	NULL
Birckbichler	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Rice	NULL
.	NULL

1992	NULL
.	NULL

Transglutami-nases	NULL
:	NULL
multifunctional	NULL
cross-linking	NULL
enzymes	NULL
that	NULL
stabilize	NULL
tissues	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

5:3071-3077	NULL
.	NULL

Haas-Kogan	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
S.	NULL
C.	NULL
Kogan	NULL
,	NULL
D.	NULL
Levi	NULL
,	NULL
P.	NULL
A.	NULL
Dazin	NULL
T'Ang	NULL
,	NULL
Y.-K.	NULL
T.	NULL
Fung	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Israel	NULL
.	NULL

1995	NULL
.	NULL

Inhibition	NULL
of	NULL
apoptosis	NULL
by	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:461-472	NULL
.	NULL

Hale	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
C.	NULL
A.	NULL
Smith	NULL
,	NULL
L.	NULL
C.	NULL
Sutherland	NULL
,	NULL
V.	NULL
E.	NULL
A.	NULL
Stoneman	NULL
,	NULL
V.	NULL
L.	NULL
Longth-orne	NULL
,	NULL
A.	NULL
C.	NULL
Culhane	NULL
,	NULL
and	NULL
G.	NULL
T.	NULL
Williams	NULL
.	NULL

1996	NULL
.	NULL

Apoptosis	NULL
:	NULL
molecular	NULL
regulation	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

236:1-26	NULL
.	NULL

Hateboer	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
M.	NULL
Kerkhoven	NULL
,	NULL
A.	NULL
Shvarts	NULL
,	NULL
R.	NULL
Bernards	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Beijers-bergen	NULL
.	NULL

1996	NULL
.	NULL

Degradation	NULL
of	NULL
E2F	NULL
by	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
:	NULL
regulation	NULL
by	NULL
retinoblastoma	NULL
family	NULL
proteins	NULL
and	NULL
adenovirus	NULL
transforming	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:2960-2970	NULL
.	NULL

Haupt	NULL
,	NULL
Y.	NULL
,	NULL
S.	NULL
Rowan	NULL
,	NULL
and	NULL
M.	NULL
Oren	NULL
.	NULL

1995.	NULL
p53-mediated	NULL
apoptosis	NULL
in	NULL
HeLa	NULL
cells	NULL
can	NULL
be	NULL
overcome	NULL
by	NULL
excess	NULL
pRB	NULL
.	NULL

Oncogene	NULL
10:1563-1571	NULL
.	NULL

Hofmann	NULL
,	NULL
F.	NULL
,	NULL
F.	NULL
Martelli	NULL
,	NULL
D.	NULL
M.	NULL
Livingston	NULL
,	NULL
and	NULL
Z.	NULL
Wang	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
protects	NULL
E2F-1	NULL
from	NULL
degradation	NULL
by	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

10:2949-2959	NULL
.	NULL

Jacobson	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
J.	NULL
F.	NULL
Burne	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Raff	NULL
.	NULL

1994	NULL
.	NULL

Programmed	NULL
cell	NULL
death	NULL
and	NULL
Bcl-2	NULL
protection	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
nucleus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:1899-1910	NULL
.	NULL

Janicke	NULL
,	NULL
R.	NULL
U.	NULL
,	NULL
P.	NULL
A.	NULL
Walker	NULL
,	NULL
X.	NULL
Y.	NULL
Lin	NULL
,	NULL
and	NULL
A.	NULL
G.	NULL
Porter	NULL
.	NULL

1996	NULL
.	NULL

Specific	NULL
cleavage	NULL
of	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
by	NULL
an	NULL
ICE-like	NULL
protease	NULL
in	NULL
apoptosis	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:6969-6978	NULL
.	NULL

Jarvis	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
A.	NULL
J.	NULL
Turner	NULL
,	NULL
L.	NULL
F.	NULL
Povick	NULL
,	NULL
R.	NULL
S.	NULL
Traylor	NULL
,	NULL
and	NULL
S.	NULL
Grant	NULL
.	NULL

1994	NULL
.	NULL

Induction	NULL
of	NULL
apoptotic	NULL
DNA	NULL
fragmentation	NULL
and	NULL
cell	NULL
death	NULL
in	NULL
HL-60	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
by	NULL
pharmacological	NULL
inhibitors	NULL
of	NULL
protein	NULL
kinase	NULL
C.	NULL
Cancer	NULL
Res	NULL
.	NULL

54:1707-1714	NULL
.	NULL

Jones	NULL
,	NULL
T.	NULL
L.	NULL
,	NULL
and	NULL
D.	NULL
Lafrenz	NULL
.	NULL

1992	NULL
.	NULL

Quantitative	NULL
determination	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
a	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
using	NULL
flow	NULL
cytometric	NULL
bivariate	NULL
cell	NULL
cycle	NULL
analysis	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

142:348-360.	NULL
.	NULL

Knight	NULL
,	NULL
C.	NULL
R.	NULL
L.	NULL
,	NULL
D.	NULL
Hand	NULL
,	NULL
M.	NULL
Piacentini	NULL
,	NULL
and	NULL
M.	NULL
Griffin	NULL
.	NULL

1993	NULL
.	NULL

Character	NULL
ization	NULL
of	NULL
the	NULL
transglutaminase-mediated	NULL
large	NULL
molecular	NULL
weight	NULL
polymer	NULL
from	NULL
rat	NULL
liver	NULL
;	NULL
its	NULL
relationship	NULL
to	NULL
apoptosis	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

60:210-217	NULL
.	NULL

Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
C.	NULL
Miller	NULL
,	NULL
M.	NULL
A.	NULL
Nicolson	NULL
,	NULL
J.	NULL
Ranyard	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Bosselman	NULL
.	NULL

1986	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
p53	NULL
protein	NULL
in	NULL
human	NULL
leukemia	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:4035-4039	NULL
.	NULL

Kumar	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Lavin	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
ICE	NULL
family	NULL
of	NULL
cysteine	NULL
proteases	NULL
as	NULL
effectors	NULL
of	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
Death	NULL
Differ	NULL
.	NULL

3:255-268	NULL
.	NULL

Leszezynski	NULL
,	NULL
D.	NULL
,	NULL
Y.	NULL
Zhao	NULL
,	NULL
M.	NULL
Luokkamaki	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Foegh	NULL
.	NULL

1994	NULL
.	NULL

Apoptosis	NULL
of	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
and	NULL
oncoprotein	NULL
Bcl-2	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
apoptosis	NULL
in	NULL
non-transformed	NULL
rat	NULL
vascular	NULL
smooth	NULL
muscle	NULL
cells	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

145:1265-1270	NULL
.	NULL

Martel	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Batsché	NULL
,	NULL
F.	NULL
Harper	NULL
,	NULL
and	NULL
C.	NULL
Cremisi	NULL
.	NULL

1996	NULL
.	NULL

Inactivation	NULL
of	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

retinoblastoma	NULL
gene	NULL
product	NULL
RB	NULL
or	NULL
an	NULL
RB-related	NULL
protein	NULL
by	NULL
SV40	NULL
T	NULL
antigen	NULL
in	NULL
MDCK	NULL
epithelial	NULL
cells	NULL
results	NULL
in	NULL
massive	NULL
apoptosis	NULL
.	NULL

Cell	NULL
Death	NULL
Differ	NULL
.	NULL

3:285-298	NULL
.	NULL

Melino	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Annicchiarico-Petruzzelli	NULL
,	NULL
L.	NULL
Piredda	NULL
,	NULL
E.	NULL
Candi	NULL
,	NULL
V.	NULL
Gentile	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

A.	NULL
Davies	NULL
,	NULL
and	NULL
M.	NULL
Piacentini	NULL
.	NULL

1994	NULL
.	NULL

``	NULL
Tissue	NULL
``	NULL
transglutaminase	NULL
and	NULL
apoptosis	NULL
:	NULL
sense	NULL
and	NULL
antisense	NULL
transfection	NULL
studies	NULL
in	NULL
human	NULL
neuroblastoma	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6584-6596	NULL
.	NULL

Messmer	NULL
,	NULL
U.	NULL
D.	NULL
,	NULL
E.	NULL
G.	NULL
Lapetina	NULL
,	NULL
and	NULL
B.	NULL
Briine	NULL
.	NULL

1995	NULL
.	NULL

Nitric	NULL
oxide-induced	NULL
apoptosis	NULL
in	NULL
RAW	NULL
264.7	NULL
macrophages	NULL
is	NULL
antagonized	NULL
by	NULL
protein	NULL
kinase	NULL
C-and	NULL
protein	NULL
kinase	NULL
A-activating	NULL
compounds	NULL
.	NULL

Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

47:757-765	NULL
.	NULL

Morgenbesser	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
B.	NULL
O.	NULL
Williams	NULL
,	NULL
T.	NULL
K.	NULL
Jacks	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
DePinho	NULL
.	NULL

1994.	NULL
pS3-dependent	NULL
apoptosis	NULL
produced	NULL
by	NULL
Rb-deficiency	NULL
in	NULL
the	NULL
developing	NULL
mouse	NULL
lens	NULL
.	NULL

Nature	NULL
371:72-74	NULL
.	NULL

Miiller	NULL
,	NULL
R.	NULL
1995	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
during	NULL
the	NULL
mammalian	NULL
cell	NULL
cycle	NULL
.	NULL

Trends	NULL
Genet	NULL
.	NULL

11:173-178	NULL
.	NULL

Nakaoka	NULL
,	NULL
H.	NULL
,	NULL
D.	NULL
M.	NULL
Perez	NULL
,	NULL
K.	NULL
J.	NULL
Baek	NULL
,	NULL
T.	NULL
Das	NULL
,	NULL
A.	NULL
Husain	NULL
,	NULL
K.	NULL
Misono	NULL
,	NULL
M.	NULL
Im	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Graham	NULL
.	NULL

1994	NULL
.	NULL

Gh	NULL
:	NULL
a	NULL
GTP-binding	NULL
protein	NULL
with	NULL
transglutaminase	NULL
activity	NULL
and	NULL
receptor	NULL
signaling	NULL
function	NULL
.	NULL

Science	NULL
264:1593-1596	NULL
.	NULL

Nemes	NULL
,	NULL
Z.	NULL
,	NULL
R.	NULL
Adany	NULL
,	NULL
M.	NULL
Balazs	NULL
,	NULL
P.	NULL
Boross	NULL
,	NULL
and	NULL
L.	NULL
Fesus	NULL
.	NULL

Identification	NULL
of	NULL
cytoplasmic	NULL
actin	NULL
as	NULL
an	NULL
abundant	NULL
glutaminyl	NULL
substrate	NULL
for	NULL
tissue	NULL
transglutaminase	NULL
in	NULL
HL6O0	NULL
and	NULL
U937	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

Piacentini	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Sartori	NULL
,	NULL
S.	NULL
Beninati	NULL
,	NULL
A.	NULL
M.	NULL
Bargagli	NULL
,	NULL
and	NULL
M.	NULL
P.	NULL
Argento-Ceri	NULL
.	NULL

1986	NULL
.	NULL

Ornithine	NULL
decarboxylase	NULL
,	NULL
transglutaminase	NULL
,	NULL
diamine	NULL
oxidase	NULL
and	NULL
total	NULL
diamines	NULL
and	NULL
polyamines	NULL
in	NULL
maternal	NULL
liver	NULL
and	NULL
kidney	NULL
throughout	NULL
rat	NULL
pregnancy	NULL
.	NULL

Biochem	NULL
.	NULL

J	NULL
.	NULL

234:435-440	NULL
.	NULL

Piacentini	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Martinet	NULL
,	NULL
S.	NULL
Beninati	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Folk	NULL
.	NULL

1988	NULL
.	NULL

Free	NULL
and	NULL
protein-conjugated	NULL
polyamines	NULL
in	NULL
mouse	NULL
epidermal	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

263:3790-3794	NULL
.	NULL

Piacentini	NULL
,	NULL
M.	NULL
,	NULL
F.	NULL
Autuori	NULL
,	NULL
L.	NULL
Dini	NULL
,	NULL
M.	NULL
G.	NULL
Farrace	NULL
,	NULL
L.	NULL
Ghibelli	NULL
,	NULL
L.	NULL
Piredda	NULL
,	NULL
and	NULL
L.	NULL
Fesus	NULL
.	NULL

1991	NULL
.	NULL

``	NULL
Tissue	NULL
``	NULL
transglutaminase	NULL
is	NULL
specifically	NULL
expressed	NULL
in	NULL
neonatal	NULL
rat	NULL
liver	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
upon	NULL
epidermal	NULL
growth	NULL
factor-stimulation	NULL
.	NULL

Cell	NULL
Tissue	NULL
Res	NULL
.	NULL

263:227-235	NULL
.	NULL

Piacentini	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

A.	NULL
Davies	NULL
,	NULL
and	NULL
L.	NULL
Fesus	NULL
.	NULL

1994	NULL
.	NULL

Transglutaminase	NULL
in	NULL
cells	NULL
undergoing	NULL
apoptosis	NULL
,	NULL
p.	NULL
143-163	NULL
.	NULL

In	NULL
L.	NULL
D.	NULL
Tomei	NULL
and	NULL
F.	NULL
O	NULL
.	NULL

Cope	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Apoptosis	NULL
:	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
apoptosis	NULL
in	NULL
disease	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Piacentini	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Piredda	NULL
,	NULL
D.	NULL
Starace	NULL
,	NULL
M.	NULL
Annichiarico-Petruzzelli	NULL
,	NULL
M.	NULL
Mat-tei	NULL
,	NULL
S.	NULL
Oliverio	NULL
,	NULL
M.	NULL
G.	NULL
Farrace	NULL
,	NULL
and	NULL
G.	NULL
Melino	NULL
.	NULL

1996	NULL
.	NULL

Differential	NULL
growth	NULL
of	NULL
N-	NULL
and	NULL
S-type	NULL
human	NULL
neuroblastoma	NULL
cells	NULL
xenografted	NULL
into	NULL
SCID	NULL
mice	NULL
.	NULL

Correlation	NULL
with	NULL
apoptosis	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

180:31-38	NULL
.	NULL

Piredda	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Amendola	NULL
,	NULL
V.	NULL
Colizzi	NULL
,	NULL
P.	NULL
J	NULL
.	NULL

A.	NULL
Davies	NULL
,	NULL
M.	NULL
G.	NULL
Farrace	NULL
,	NULL
M.	NULL
Fraziano	NULL
,	NULL
V.	NULL
Gentile	NULL
,	NULL
I.	NULL
Uray	NULL
,	NULL
M.	NULL
Piacentini	NULL
,	NULL
and	NULL
L.	NULL
Fesus	NULL
.	NULL

1997	NULL
.	NULL

Lack	NULL
of	NULL
``	NULL
tissue	NULL
``	NULL
transglutaminase	NULL
protein	NULL
cross-linking	NULL
leads	NULL
to	NULL
leakage	NULL
of	NULL
macro-molecules	NULL
from	NULL
dying	NULL
cells	NULL
:	NULL
relationship	NULL
to	NULL
development	NULL
of	NULL
autoimmunity	NULL
in	NULL
MRLipr/ipr	NULL
mice	NULL
.	NULL

Cell	NULL
Death	NULL
Differ	NULL
.	NULL

4:463-472	NULL
.	NULL

Slack	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
I.	NULL
S.	NULL
Skerjanc	NULL
,	NULL
B.	NULL
Lach	NULL
,	NULL
J.	NULL
Craig	NULL
,	NULL
K.	NULL
Jardine	NULL
,	NULL
and	NULL
M.	NULL
W.	NULL
McBurney	NULL
.	NULL

1995	NULL
.	NULL

Cells	NULL
differentiating	NULL
into	NULL
neuroectoderm	NULL
undergo	NULL
apoptosis	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
functional	NULL
retinoblastoma	NULL
family	NULL
proteins	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

129:779-788	NULL
.	NULL

Weinberg	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
retinoblastoma	NULL
product	NULL
and	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Cell	NULL
§1:323-330	NULL
.	NULL

White	NULL
,	NULL
E.	NULL
1994.	NULL
p53	NULL
,	NULL
guardian	NULL
of	NULL
Rb	NULL
.	NULL

Nature	NULL
371:21-22	NULL
.	NULL

Wu	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Levine	NULL
.	NULL

1994.	NULL
p53	NULL
and	NULL
E2F-1	NULL
cooperate	NULL
to	NULL
mediate	NULL
apoptosis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3602-3606	NULL
.	NULL

Xu	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
K.	NULL
Xu	NULL
,	NULL
Y.	NULL
Zhou	NULL
,	NULL
J.	NULL
Li	NULL
,	NULL
W.	NULL
F.	NULL
Benedict	NULL
,	NULL
and	NULL
S.~X	NULL
.	NULL

Hu	NULL
.	NULL

1994	NULL
.	NULL

Enhanced	NULL
tumor	NULL
cell	NULL
growth	NULL
suppression	NULL
by	NULL
an	NULL
N-terminal	NULL
truncated	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:9837-9841	NULL
.	NULL

